Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3,4-dichloroisocoumarin + H2O
?
Substrates: a significant portion of the inhibitor 3,4-dichloroisocoumarin bound to GlpG is enzymatically turned over
Products: -
?
acetyl-RRRAVFLA-7-amido-4-methyl-2H-1-benzopyran-2-one + H2O
acetyl-RRRAVFLA + 7-amino-4-methyl-2H-1-benzopyran-2-one
-
Substrates: -
Products: -
?
acetyl-RVRHA-7-amido-4-methyl-2H-1-benzopyran-2-one + H2O
acetyl-RVRHA + 7-amino-4-methyl-2H-1-benzopyran-2-one
-
Substrates: -
Products: -
?
adhesin + H2O
?
-
Substrates: EhROM1 is able to cleave Plasmodium adhesins but not the canonical substrate Drosophila Spitz. It is examined whether EhROM1 can cleave a representative of each of the four families of Plasmodium adhesins: the EBL adhesin BAEBL, the RBL adhesin Rh4, AMA1, and TRAP. All adhesins are efficient substrates for the recoded EhROM1 with the exception of AMA1, which is cleaved less well than the others by EhROM1
Products: -
?
adhesin BAEBL + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin CTRP + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin EBA-175 + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin EBP-175 + H2O
?
-
Substrates: adhesin EBP-175 of Plasmodium falciparum undergoes ectodomain shedding, in a reaction catalyzed by plasmodium rhomboid pfROM4. pfROM4 cleaves within the transmembrane region of the adhesin
Products: -
?
adhesin JESEBL + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin MAEBL + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin MTRAP + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin PFF0800c + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin Rh1 + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin Rh24 + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin Rh2a + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin Rh2b + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin TRAP + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesion protein from Toxoplasma gondii + H2O
?
alpha chain of pre-T cell receptor + H2O
?
Substrates: constitutively active receptor variant required for T cell development. cleavage contributes to ER-associated degradation, cleavage productsare translocated and degraded by the proteasome
Products: -
?
ALQLAACGLAGGSAAVLFSAVAVGKPRAGGDAEP + H2O
ALQLAACGLAGGSAAVLF + SAVAVGKPRAGGDAEP
-
Substrates: -
Products: -
?
amyloid precursor protein + H2O
?
apical membrane antigen 1 + H2O
?
-
Substrates: i.e. AMA1, substrate only of ROM1
Products: -
?
apical membrane antigen AMA1 + H2O
?
Substrates: -
Products: -
?
APP-Spi7-Flag + H2O
?
Substrates: -
Products: -
?
Bcl-2-interacting killer + H2O
?
Substrates: -
Products: -
?
beta-lactamase Spitz transmembrane domain + H2O
?
-
Substrates: 34 residue peptide, sequence KRPRPMLEKASIASGAMCALVFMLFVCLAFYLRK
Products: -
?
beta-lactamase-Spitz transmembrane segment-maltose binding protein + H2O
?
-
Substrates: a fusion protein containing the Spitz TM segment fused to globular proteins at the N- and C-termini (beta-lactamase and maltose binding protein, respectively)
Products: -
?
beta-secretase mutant BACE476DELTA + H2O
50 kDa BACE476DELTA fragment + ?
-
Substrates: -
Products: -
?
Bla-GknTM-MBP + H2O
?
Substrates: recombinantly expressed fusion protein having the transmembrane region of Gurken, GknTM, a physiological substrate of Drosophila rhomboids, GlpG cleaves an extramembrane region of the substrate exposed to the periplasm, overview
Products: -
?
C100Tat-Flag + H2O
?
Substrates: C100Tat-Flag is a chimera of the C-terminal 100 residues of APP, with seven residues of the Pseudomonas stuartii TatA cleavage site substituted at the N-terminus
Products: -
?
Ccp1 + H2O
?
-
Substrates: Ccp1 is a mitochondrial cytochrome c peroxidase its cleavage side resides in a short stretch of moderately hydrophobic sequence
Products: -
?
chimeric protein of the bacterial pelB leader peptide, GFP as the extracellularectodomain, the juxtamembrane-transmembrane-cytosolic residues 122-230 of Spitz and a C-terminal epitope + H2O
?
CyPet-TatA-YPet + H2O
?
Substrates: engineered substrate based on transmembrane substrate TatA from Providencia stuartii, suitable for FRET assay
Products: -
?
cytochrome c peroxidase + H2O
processed cytochrome c peroxidase + targeting sequence peptide
-
Substrates: cleaving the targeting sequence of cytochrome c peroxidase, Pcp1
Products: -
?
cytochrome c peroxidase Ccp1 + H2O
?
-
Substrates: cleavage of Ccp1 by Pcp1/Rbd1 appears to occur directly after or within its hydrophobic sorting sequence
Products: -
?
cytochrome c peroxidase precursor + H2O
cytochrome c peroxidase + ?
Delta-transmembrane domain + H2O
?
dynamin-like GTPase + H2O
?
-
Substrates: -
Products: -
?
epidermal growth factor + H2O
?
-
Substrates: efficient and specific substrate for rhomboid protease RHBDL2
Products: -
?
fatty acid export protein 1 + H2O
?
-
Substrates: the enzyme and fatty acid export protein 1 interact physically at the inner envelope membrane of chloroplasts
Products: -
?
FdnH + H2O
?
-
Substrates: substrate of enzyme forms GlpG and Rhom7
Products: -
?
FdoH + H2O
?
-
Substrates: substrate of enzyme form GlpG
Products: -
?
growth factor Spitz + H2O
?
growth-factor gurken + H2O
?
-
Substrates: -
Products: -
?
growth-factor spitz + H2O
?
-
Substrates: -
Products: -
?
Gurken protein + H2O
PQRKVRMA + HIVFSFFV
Gurken-derived peptide + H2O
?
Gurken-transmembrane domain + H2O
?
HybO + H2O
?
-
Substrates: substrate of enzyme forms GlpG and Rhom7
Products: -
?
Keren protein + H2O
?
-
Substrates: -
Products: -
?
l-Mgm1 + H2O
s-Mgm1 + N-terminal putative transmembrane segment
LacY trans-membrane domain 2 + H2O
?
LacYTM2 + H2O
?
-
Substrates: -
Products: -
?
LacYTM2 protein + H2O
DINHISKS + DTGIIFAA
large isoform of Mgm1 + H2O
short isoform of Mgm1 + ?
lectin + H2O
?
-
Substrates: EhROM1 is able to cleave cell surface lectin
Products: -
?
Mca-Arg-Pro-Lys-Pro-Tyr-Ala-Nva-Trp-Met-Lys(Dnp)-NH2 + H2O
?
Substrates: -
Products: -
?
MHC202 + H2O
18 kDa N-terminal MHC202 fragment + ?
-
Substrates: -
Products: -
?
microneme protein MIC2 + H2O
?
Substrates: -
Products: -
?
microneme protein MIC6 + H2O
?
Substrates: -
Products: -
?
myelin protein zero mutant L170R + H2O
?
Substrates: mutant form is unstable and efficiently cleaved by isoform RHBDL4. Wild-type myelin protein zero is not a substrate
Products: -
?
N-acetyl-PEG4-QRKVRMAHIVFSFPC-amide + H2O
N-acetyl-PEG4-QRKVRMA + HIVFSFPC-amide
oligosaccharyl transferase + H2O
?
Substrates: -
Products: -
?
Opa-1 + H2O
?
-
Substrates: genetic analysis shows that Opa1 and Parl are part of the same pathway, with Parl positioned upstream of Opa1 in the control of apoptosis
Products: -
?
opsin mutant bearing TCRalpha degron motif + H2O
?
Substrates: opsin-degron mutant is degraded by isoform RHBDL4, whereas the wild-type protein is stable
Products: -
?
Orm2 + H2O
?
-
Substrates: -
Products: -
?
phosphoglycerate mutase 5 + H2O
?
Substrates: mitochondrial Ser/Thr protein phosphatase PGAM5
Products: substrate is cleaved in its N-terminal transmembrane domain in response to mitochondrial membrane potential loss and mediated by presenilin-associated rhomboid-like protein. In response to membrane potential loss, the enzyme dissociates from substrate PINK1, a mitochondrial Ser/Thr protein kinase, and reciprocally associates with substrate PGAM5. Results suggest that the enzyme mediates differential cleavage of PINK1 and PGAM5 depending on the health status of mitochondria
?
polycystin-1 + H2O
?
Substrates: 11-TM spanning membrane protein. Isoform RHBDL4 cleaves several truncated versions of polycystin-1 at luminal loops or juxtamembrane transmembrane regions. Wild-type olycystin-1 is not a substrate
Products: -
?
pre T-cell receptor substrate alpha + H2O
?
Substrates: -
Products: -
?
Protein + H2O
?
-
Substrates: cleaves a model protein having an N-terminal and periplasmically localized beta-lactamase domain, a LacY-derived transmembrane region, and a cytosolic maltose binding protein mature domain, cleavage occurs between Ser and Asp in a region of high local hydrophilicity, which might be located iin a juxtamembrane rather than an intramembrane position. The conserved Ser and His residue of GlpG are esential for proteolytic activity
Products: -
?
protein Bla-LY2-MBP + H2O
?
protein MIC2 + H2O
?
Substrates: cleavage at an Ala-Gly bond
Products: -
?
reporter substrate LY2
?
Substrates: using a combinatorial approach it is shown that a negatively charged residue is the primary determinant of cleavage. The amino acid preceding peptide bond hydrolysis (the P1 position) has a preference for the small and polar Ser residue. The amino acid succeeding peptide bond hydrolysis (the P1 position) has a preference for negatively charged Asp
Products: -
?
Smac/Diablo + H2O
?
-
Substrates: fastest cleaved substrate
Products: -
?
Spitz-polyA + H2O
?
Substrates: -
Products: -
?
Spitz-transmembrane domain + H2O
?
SREBP-1c + H2O
?
-
Substrates: -
Products: -
?
sterol regulatory element-binding protein 1 + H2O
?
Substrates: -
Products: -
?
TatA + H2O
processed TatA + N-terminal extension peptide
TatA protein + H2O
MESTIATA + AFGSPWQL
thrombomodulin + H2O
soluble thrombomodulin + ?
-
Substrates: -
Products: -
?
Tic40 + H2O
?
-
Substrates: i.e. the chloroplast inner envelope translocon component of 40 kDa
Products: -
?
trans-membrane domain + H2O
?
trans-membrane domain Gurken + H2O
?
tumor suppressor-activated pathway-6 + H2O
?
Substrates: -
Products: -
?
type I membrane protein RPN1 + H2O
?
-
Substrates: -
Products: -
?
YqjD + H2O
?
-
Substrates: substrate of enzyme form GlpG
Products: -
?
YtjC + H2O
?
-
Substrates: substrate of enzyme form GlpG
Products: -
?
additional information
?
-
adhesin MIC2 + H2O

?
Substrates: -
Products: -
?
adhesin MIC2 + H2O
?
-
Substrates: the ectodomain of Toxoplasma gondii adhesin MIC2, a type-I membrane protein is cleaved by rhomboid
Products: -
?
adhesion protein from Toxoplasma gondii + H2O

?
-
Substrates: MIC-2, MIC-6 and MIC-12 are efficient substrates
Products: -
?
adhesion protein from Toxoplasma gondii + H2O
?
-
Substrates: MIC-2, MIC-6 and MIC-12 are efficient substrates
Products: -
?
amyloid precursor protein + H2O

?
-
Substrates: -
Products: -
?
amyloid precursor protein + H2O
?
Substrates: -
Products: -
?
BODIPY FL casein + H2O

?
Substrates: -
Products: -
?
BODIPY FL casein + H2O
?
Substrates: commercially available fluorescent substrate
Products: -
?
C100Spi-Flag + H2O

?
-
Substrates: no cleavage of C100-Flag
Products: -
?
C100Spi-Flag + H2O
?
-
Substrates: no cleavage of C100-Flag
Products: -
?
C100Spi-Flag + H2O
?
-
Substrates: no cleavage of C100-Flag
Products: -
?
C100Spi-Flag + H2O
?
-
Substrates: no cleavage of C100-Flag
Products: -
?
chaperone Star + H2O

?
-
Substrates: cleavage of Star within its transmembrane domain both in cell culture and in flies, the enzyme is involved in regulation of levels of Spitz, the major Drosophila EGF receptor ligand, mechanism for modulating the activity of Star, thereby influencing the levels of active Spitz ligand, intracellular trafficking of Spitz isimpaired by Rhomboid-dependent cleavage of Star, overview
Products: -
?
chaperone Star + H2O
?
-
Substrates: a type II transmembrane protein, cleavage in the transmembrane sequence 298IVYMoxDTTEIRHQQF311
Products: -
?
chimeric protein of the bacterial pelB leader peptide, GFP as the extracellularectodomain, the juxtamembrane-transmembrane-cytosolic residues 122-230 of Spitz and a C-terminal epitope + H2O

?
-
Substrates: -
Products: -
?
chimeric protein of the bacterial pelB leader peptide, GFP as the extracellularectodomain, the juxtamembrane-transmembrane-cytosolic residues 122-230 of Spitz and a C-terminal epitope + H2O
?
-
Substrates: -
Products: -
?
cytochrome c peroxidase precursor + H2O

cytochrome c peroxidase + ?
-
Substrates: -
Products: -
?
cytochrome c peroxidase precursor + H2O
cytochrome c peroxidase + ?
Substrates: -
Products: -
?
Delta-transmembrane domain + H2O

?
-
Substrates: slight activity
Products: -
?
Delta-transmembrane domain + H2O
?
-
Substrates: slight activity
Products: -
?
ephrin B3 + H2O

?
-
Substrates: RHBDL-2 mediated proteolytic processing may regulate intercellular interactions between ephrinB3 and eph receptors
Products: -
?
ephrin B3 + H2O
?
-
Substrates: cleaved efficiently, appears to be cleaved in its membrane domain
Products: -
?
FL-casein + H2O

?
-
Substrates: -
Products: -
?
FL-casein + H2O
?
Substrates: -
Products: -
?
FL-casein + H2O
?
Substrates: -
Products: -
?
FL-casein + H2O
?
Substrates: -
Products: -
?
growth factor Spitz + H2O

?
-
Substrates: -
Products: -
?
growth factor Spitz + H2O
?
-
Substrates: Rhomboid-1 is important in extracellular signal production, overview
Products: -
?
growth factor Spitz + H2O
?
-
Substrates: Rhomboid-1
Products: -
?
Gurken + H2O

?
Substrates: -
Products: -
?
Gurken + H2O
?
-
Substrates: -
Products: -
?
Gurken + H2O
?
-
Substrates: cleavage by rhomboid 4
Products: -
?
Gurken + H2O
?
-
Substrates: -
Products: -
?
Gurken + H2O
?
-
Substrates: -
Products: -
?
Gurken protein + H2O

?
-
Substrates: -
Products: -
?
Gurken protein + H2O
?
-
Substrates: -
Products: -
?
Gurken protein + H2O
?
Substrates: -
Products: -
?
Gurken protein + H2O

PQRKVRMA + HIVFSFFV
-
Substrates: -
Products: -
?
Gurken protein + H2O
PQRKVRMA + HIVFSFFV
-
Substrates: -
Products: -
?
Gurken protein + H2O
PQRKVRMA + HIVFSFFV
-
Substrates: -
Products: -
?
Gurken-derived peptide + H2O

?
-
Substrates: -
Products: -
?
Gurken-derived peptide + H2O
?
-
Substrates: -
Products: -
?
Gurken-transmembrane domain + H2O

?
-
Substrates: -
Products: -
?
Gurken-transmembrane domain + H2O
?
-
Substrates: -
Products: -
?
Gurken-transmembrane domain + H2O
?
Substrates: -
Products: -
?
Gurken-transmembrane domain + H2O
?
-
Substrates: -
Products: -
?
Gurken-transmembrane domain + H2O
?
-
Substrates: -
Products: -
?
Hmg2 + H2O

?
-
Substrates: -
Products: -
?
Hmg2 + H2O
?
Substrates: -
Products: -
?
HybA + H2O

?
-
Substrates: physiological substrate of enzyme forms GlpG and Rhom7
Products: -
?
HybA + H2O
?
-
Substrates: substrate of enzyme forms GlpG and Rhom7
Products: -
?
Keren + H2O

?
Substrates: -
Products: -
?
Keren + H2O
?
-
Substrates: Rho-1 recognizes a common region of the transmembrane helix substrate that contains small residues (Gly,Ser,Ala)
Products: -
?
Keren + H2O
?
-
Substrates: -
Products: -
?
Keren + H2O
?
-
Substrates: cleavage by rhomboid 4
Products: -
?
Keren + H2O
?
-
Substrates: -
Products: -
?
Keren + H2O
?
-
Substrates: -
Products: -
?
Keren + H2O
?
-
Substrates: inefficient cleavage
Products: -
?
l-Mgm1 + H2O

s-Mgm1 + N-terminal putative transmembrane segment
-
Substrates: rhomboid-type protease Pcp1 is essential for wild type mitochondrial morphology. The processing of the large isoform l-Mgm1 by rhomboid-type protease Pcp1 to s-Mgm1, and the presence of both isoforms of Mgm1 appears to be crucial for wild-type mitochondrial morphology and maintenance of mitochondrial DNA
Products: -
?
l-Mgm1 + H2O
s-Mgm1 + N-terminal putative transmembrane segment
-
Substrates: l-Mgm1 is the large isoform of Mgm1
Products: s-Mgm1 is the small isoform of Mgm1
?
LacY trans-membrane domain 2 + H2O

?
Substrates: LacY trans-membrane domain 2 of Escherichia coli is engineered into a fusion protein backbone that includes a signal peptide and maltose-binding protein N-terminal to the trans-membrane domain, and a thioredoxin domain and His tag at the C terminus. Substrate is cleaved at the same position by different bacterial rhomboids. Insertion into a fusion protein does not affect cleavage
Products: -
?
LacY trans-membrane domain 2 + H2O
?
Substrates: LacY trans-membrane domain 2 of Escherichia coli is engineered into a fusion protein backbone that includes a signal peptide and maltose-binding protein N-terminal to the trans-membrane domain, and a thioredoxin domain and His tag at the C terminus. Substrate is cleaved at the same position by different bacterial rhomboids. Insertion into a fusion protein does not affect cleavage
Products: -
?
LacY trans-membrane domain 2 + H2O
?
Substrates: LacY trans-membrane domain 2 of Escherichia coli is engineered into a fusion protein backbone that includes a signal peptide and maltose-binding protein N-terminal to the trans-membrane domain, and a thioredoxin domain and His tag at the C terminus. Substrate is cleaved at the same position by different bacterial rhomboids. Insertion into a fusion protein does not affect cleavage
Products: -
?
LacYTM2 protein + H2O

DINHISKS + DTGIIFAA
-
Substrates: -
Products: -
?
LacYTM2 protein + H2O
DINHISKS + DTGIIFAA
-
Substrates: -
Products: -
?
LacYTM2 protein + H2O
DINHISKS + DTGIIFAA
-
Substrates: -
Products: -
?
large isoform of Mgm1 + H2O

short isoform of Mgm1 + ?
-
Substrates: the enzyme is involved in the pathway of Mgm1 biogenesis. A strong shift in the ratio between both isoform of Mgm1 is sufficient to alter mitochondrial morphology
Products: -
?
large isoform of Mgm1 + H2O
short isoform of Mgm1 + ?
-
Substrates: -
Products: -
?
Mgm1 + H2O

?
-
Substrates: cleaving the long isoform of Mgm1 to produce the short one
Products: -
?
Mgm1 + H2O
?
-
Substrates: Mgm1 is a dynamin-like GTPase its cleavage side resides in a short stretch of moderately hydrophobic sequence
Products: -
?
Mgm1p + H2O

?
-
Substrates: inner membrane dynamin-related protein is cleaved by Pcp1/Rbd1. In Mgm1p, substituting GlyGlyMet in the predicted transmembrane helix with bulkier ValValLeu blocks Pcp1/Rbd1-mediated cleavage, suggesting that the GlyGly substrate motif of RHO rhomboids is also important for PARL rhomboids
Products: -
?
Mgm1p + H2O
?
-
Substrates: transmembrane helix Mgm1p (inner membrane dynamin-related protein) of Schizosaccharomyces pombe is cleaved at different place than Mgm1p of Schizosaccharomyces cerevisiae
Products: -
?
MIC adhesin + H2O

?
-
Substrates: only TgRMO5 is able to cleave MIC adhesins, it likely provides the key protease activity necessary for invasion
Products: -
?
MIC adhesin + H2O
?
-
Substrates: -
Products: -
?
MIC adhesin + H2O
?
-
Substrates: only TgRMO5 is able to cleave MIC adhesins, it likely provides the key protease activity necessary for invasion
Products: -
?
MIC adhesin + H2O
?
-
Substrates: -
Products: -
?
MIC adhesin + H2O
?
-
Substrates: only TgRMO5 is able to cleave MIC adhesins, it likely provides the key protease activity necessary for invasion
Products: -
?
MIC adhesin + H2O
?
-
Substrates: -
Products: -
?
MIC adhesin + H2O
?
-
Substrates: only TgRMO5 is able to cleave MIC adhesins, it likely provides the key protease activity necessary for invasion
Products: -
?
MIC adhesin + H2O
?
-
Substrates: -
Products: -
?
MIC adhesin + H2O
?
-
Substrates: only TgRMO5 is able to cleave MIC adhesins, it likely provides the key protease activity necessary for invasion
Products: -
?
MIC adhesin + H2O
?
-
Substrates: -
Products: -
?
MIC adhesin + H2O
?
-
Substrates: only TgRMO5 is able to cleave MIC adhesins, it likely provides the key protease activity necessary for invasion
Products: -
?
MIC adhesin + H2O
?
-
Substrates: -
Products: -
?
N-acetyl-PEG4-QRKVRMAHIVFSFPC-amide + H2O

N-acetyl-PEG4-QRKVRMA + HIVFSFPC-amide
-
Substrates: i.e. peptide KSp21
Products: -
?
N-acetyl-PEG4-QRKVRMAHIVFSFPC-amide + H2O
N-acetyl-PEG4-QRKVRMA + HIVFSFPC-amide
-
Substrates: i.e. peptide KSp21
Products: -
?
N-acetyl-PEG4-QRKVRMAHIVFSFPC-amide + H2O
N-acetyl-PEG4-QRKVRMA + HIVFSFPC-amide
-
Substrates: i.e. peptide KSp21
Products: -
?
Pdr5 + H2O

?
-
Substrates: -
Products: -
?
Pdr5 + H2O
?
Substrates: -
Products: -
?
PGAM5 + H2O

?
-
Substrates: -
Products: -
?
PGAM5 + H2O
?
-
Substrates: most efficiently cleaved substrate
Products: -
?
PINK1 + H2O

?
-
Substrates: -
Products: -
?
PINK1 + H2O
?
-
Substrates: -
Products: -
?
protein Bla-LY2-MBP + H2O

?
Substrates: recombinantly expressed type I model membrane protein substrate having the second transmembrane region of lactose permease LY2 at the extramembrane region in vivo and in vitro at the predicted periplasm-membrane boundary region of LY2, the determinants for proteolysis reside within the LY2 sequence, GlpG cleaves an extramembrane region of the substrate exposed to the periplasm, overview
Products: -
?
protein Bla-LY2-MBP + H2O
?
-
Substrates: recombinantly expressed type I model membrane protein substrate having the second transmembrane region of lactose permease LY2 at the extramembrane region in vivo and in vitro, the determinants for proteolysis reside within the LY2 sequence
Products: -
?
protein Gurken + H2O

?
-
Substrates: -
Products: -
?
protein Gurken + H2O
?
-
Substrates: cleavage by rhomboid 2
Products: -
?
protein Gurken + H2O
?
-
Substrates: cleavage by rhomboid 3
Products: -
?
protein Gurken + H2O
?
-
Substrates: cleavage by rhomboid 1
Products: -
?
protein Keren + H2O

?
-
Substrates: -
Products: -
?
protein Keren + H2O
?
-
Substrates: cleavage by rhomboid 2
Products: -
?
protein Keren + H2O
?
-
Substrates: cleavage by rhomboid 3
Products: -
?
protein Keren + H2O
?
-
Substrates: cleavage by rhomboid 1
Products: -
?
protein Spitz + H2O

?
-
Substrates: rhomboids 1-4 are all dedicated to regulating EGF receptor signalling
Products: -
?
protein Spitz + H2O
?
-
Substrates: when Spitz is cleaved by rhomboids in the endoplasmic reticulum it cannot be secreted. Star regulates Spitz cleavage by rhomboid-1 by transporting Spitz to the Golgi apparatus. Rhomboids 1-4 are all dedicated to regulating EGF receptor signalling
Products: -
?
protein Spitz + H2O
?
-
Substrates: cleavage by rhomboid 2
Products: -
?
protein Spitz + H2O
?
-
Substrates: cleavage by rhomboid 3
Products: -
?
protein Spitz + H2O
?
-
Substrates: cleavage by rhomboid 1
Products: -
?
protein Spitz + H2O
?
-
Substrates: UniProt Accession Code QRHBDL2 cleaves the membrane domain of Drosophila protein Spitz, when the proteins are coexpressed in mammalian cells
Products: -
?
Spitz + H2O

?
Substrates: -
Products: -
?
Spitz + H2O
?
-
Substrates: Rho-1 recognizes a common region of the transmembrane helix substrate that contains small residues (Gly,Ser,Ala)
Products: -
?
Spitz + H2O
?
-
Substrates: rhomboids 1-4 are all dedicated to regulating EGF receptor signalling
Products: -
?
Spitz + H2O
?
-
Substrates: the rhomboid active site in directly cleaves the membrane-anchored TGFalpha-like growth factor Spitz within its transmembarne domain
Products: -
?
Spitz + H2O
?
-
Substrates: site-specific cleavage, the substrate Spitz is recognized by a small region of the Spitz transmembrane domain. This substrate motif is necessary and sufficient for cleavage
Products: -
?
Spitz + H2O
?
-
Substrates: cleavage by rhomboid 4
Products: -
?
Spitz + H2O
?
-
Substrates: -
Products: -
?
Spitz + H2O
?
-
Substrates: -
Products: -
?
Spitz + H2O
?
-
Substrates: the rhomboid active site in directly cleaves the membrane-anchored TGFalpha-like growth factor Spitz within its transmembarne domain
Products: -
?
Spitz + H2O
?
-
Substrates: -
Products: -
?
Spitz + H2O
?
-
Substrates: -
Products: -
?
Spitz protein + H2O

?
-
Substrates: -
Products: -
?
Spitz protein + H2O
?
-
Substrates: -
Products: -
?
Spitz-transmembrane domain + H2O

?
-
Substrates: -
Products: -
?
Spitz-transmembrane domain + H2O
?
-
Substrates: little activity
Products: -
?
Spitz-transmembrane domain + H2O
?
Substrates: little activity
Products: -
?
Spitz-transmembrane domain + H2O
?
-
Substrates: -
Products: -
?
Spitz-transmembrane domain + H2O
?
-
Substrates: -
Products: -
?
Ste6 + H2O

?
-
Substrates: -
Products: -
?
Ste6 + H2O
?
Substrates: -
Products: -
?
SUS + H2O

?
-
Substrates: -
Products: -
?
SUS + H2O
?
Substrates: -
Products: -
?
TatA + H2O

?
Substrates: trans-membrane domain of Providencia stuartii TatA polypeptide segment E2-G98 is engineered into a fusion protein backbone that includes a signal peptide and maltose-binding protein N-terminal to the trans-membrane domain, and a thioredoxin domain and His tag at the C terminus. Substrate is cleaved at the same position by different bacterial rhomboids. Insertion into a fusion protein does not affect cleavage
Products: -
?
TatA + H2O
?
Substrates: -
Products: -
?
TatA + H2O
?
-
Substrates: transmembrane substrate from Providencia stuartii. Binding of TatA occurs with positive cooperativity in an exosite-mediated mode of substrate binding. Exosite formation is dependent on the oligomeric state of rhomboids, and when dimers are dissociated, allosteric substrate activation is not observed
Products: -
?
TatA + H2O
?
Substrates: trans-membrane domain of Providencia stuartii TatA polypeptide segment E2-G98 is engineered into a fusion protein backbone that includes a signal peptide and maltose-binding protein N-terminal to the trans-membrane domain, and a thioredoxin domain and His tag at the C terminus. Substrate is cleaved at the same position by different bacterial rhomboids. Insertion into a fusion protein does not affect cleavage
Products: -
?
TatA + H2O
?
Substrates: transmembrane substrate from Providencia stuartii. Binding of TatA occurs with positive cooperativity in an exosite-mediated mode of substrate binding. Exosite formation is dependent on the oligomeric state of rhomboids, and when dimers are dissociated, allosteric substrate activation is not observed
Products: -
?
TatA + H2O
?
Substrates: transmembrane substrate from Providencia stuartii. Binding of TatA occurs with positive cooperativity in an exosite-mediated mode of substrate binding. Exosite formation is dependent on the oligomeric state of rhomboids, and when dimers are dissociated, allosteric substrate activation is not observed
Products: -
?
TatA + H2O
?
Substrates: trans-membrane domain of Providencia stuartii TatA polypeptide segment E2-G98 is engineered into a fusion protein backbone that includes a signal peptide and maltose-binding protein N-terminal to the trans-membrane domain, and a thioredoxin domain and His tag at the C terminus. Substrate is cleaved at the same position by different bacterial rhomboids. Insertion into a fusion protein does not affect cleavage
Products: -
?
TatA + H2O
?
Substrates: transmembrane substrate from Providencia stuartii. Binding of TatA occurs with positive cooperativity in an exosite-mediated mode of substrate binding. Exosite formation is dependent on the oligomeric state of rhomboids, and when dimers are dissociated, allosteric substrate activation is not observed
Products: -
?
TatA + H2O

processed TatA + N-terminal extension peptide
-
Substrates: rhomboid protease AarA mediates quorum-sensing by activating TatA of the twin-arginine translocase, TatA is a component of the twin-arginine translocase, Tat, protein secretion pathway and likely forms a secretion pore, TatA in Providencia stuartii has a short N-terminal extension, which is proteolytically removed by AarA, overview
Products: -
?
TatA + H2O
processed TatA + N-terminal extension peptide
-
Substrates: -
Products: -
?
TatA + H2O
processed TatA + N-terminal extension peptide
-
Substrates: rhomboid protease AarA mediates quorum-sensing by activating TatA of the twin-arginine translocase, TatA is a component of the twin-arginine translocase, Tat, protein secretion pathway and likely forms a secretion pore, TatA in Providencia stuartii has a short N-terminal extension, which is proteolytically removed by AarA, overview
Products: -
?
TatA + H2O
processed TatA + N-terminal extension peptide
-
Substrates: -
Products: -
?
TatA protein + H2O

?
-
Substrates: -
Products: -
?
TatA protein + H2O
?
-
Substrates: -
Products: -
?
TatA protein + H2O
?
Substrates: -
Products: -
?
TatA protein + H2O

MESTIATA + AFGSPWQL
-
Substrates: -
Products: -
?
TatA protein + H2O
MESTIATA + AFGSPWQL
-
Substrates: -
Products: -
?
TatA protein + H2O
MESTIATA + AFGSPWQL
-
Substrates: -
Products: -
?
thrombomodulin + H2O

?
-
Substrates: human thrombomodulin is cleaved by the human, mouse and zebrafish RHBDL2, but not by the Drosophila Rhomboid-1 and the bacterial Aara rhomboid proteases
Products: -
?
thrombomodulin + H2O
?
-
Substrates: human thrombomodulin is cleaved by the human, mouse and zebrafish RHBDL2, but not by the Drosophila Rhomboid-1 and the bacterial Aara rhomboid proteases
Products: -
?
thrombomodulin + H2O
?
-
Substrates: human thrombomodulin is cleaved by the human, mouse and zebrafish RHBDL2, but not by the Drosophila Rhomboid-1 and the bacterial Aara rhomboid proteases
Products: -
?
trans-membrane domain + H2O

?
Substrates: trans-membrane domain of Drosophila melanogaster Spitz polypeptide segment G114-L161 is engineered into a fusion protein backbone that includes a signal peptide and maltose-binding protein N-terminal to the trans-membrane domain, and a thioredoxin domain and His tag at the C terminus. Substrate is cleaved at the same position by different bacterial rhomboids. Insertion into a fusion protein does not affect cleavage
Products: -
?
trans-membrane domain + H2O
?
Substrates: trans-membrane domain of Drosophila melanogaster Spitz polypeptide segment G114-L161 is engineered into a fusion protein backbone that includes a signal peptide and maltose-binding protein N-terminal to the trans-membrane domain, and a thioredoxin domain and His tag at the C terminus. Substrate is cleaved at the same position by different bacterial rhomboids. Insertion into a fusion protein does not affect cleavage
Products: -
?
trans-membrane domain + H2O
?
Substrates: trans-membrane domain of Drosophila melanogaster Spitz polypeptide segment G114-L161 is engineered into a fusion protein backbone that includes a signal peptide and maltose-binding protein N-terminal to the trans-membrane domain, and a thioredoxin domain and His tag at the C terminus. Substrate is cleaved at the same position by different bacterial rhomboids. Insertion into a fusion protein does not affect cleavage
Products: -
?
trans-membrane domain Gurken + H2O

?
Substrates: trans-membrane domain of Drosophila melanogaster Gurken polypeptide segment A223-R271 is engineered into a fusion protein backbone that includes a signal peptide and maltose-binding protein N-terminal to the trans-membrane domain, and a thioredoxin domain and His tag at the C terminus. Substrate is cleaved at the same position by different bacterial rhomboids. Insertion into a fusion protein does not affect cleavage
Products: -
?
trans-membrane domain Gurken + H2O
?
Substrates: trans-membrane domain of Drosophila melanogaster Gurken polypeptide segment A223-R271 is engineered into a fusion protein backbone that includes a signal peptide and maltose-binding protein N-terminal to the trans-membrane domain, and a thioredoxin domain and His tag at the C terminus. Substrate is cleaved at the same position by different bacterial rhomboids. Insertion into a fusion protein does not affect cleavage
Products: -
?
trans-membrane domain Gurken + H2O
?
Substrates: trans-membrane domain of Drosophila melanogaster Gurken polypeptide segment A223-R271 is engineered into a fusion protein backbone that includes a signal peptide and maltose-binding protein N-terminal to the trans-membrane domain, and a thioredoxin domain and His tag at the C terminus. Substrate is cleaved at the same position by different bacterial rhomboids. Insertion into a fusion protein does not affect cleavage
Products: -
?
TRAP protein + H2O

?
Substrates: transmembrane protein with extracellular adhesive domains and a cytoplasmic tail linked to the actomyosin motor. Mutations in the rhomboid cleavage site impair TRAP processing and lead to its accumulation on the sporozoite surface. A TRAP mutant in which both the rhomboid-cleavage site and the alternate cleavage site are altered is non-motile and non-infectious
Products: -
?
TRAP protein + H2O
?
Substrates: transmembrane protein with extracellular adhesive domains and a cytoplasmic tail linked to the actomyosin motor. Mutations in the rhomboid cleavage site impair TRAP processing and lead to its accumulation on the sporozoite surface. A TRAP mutant in which both the rhomboid-cleavage site and the alternate cleavage site are altered is non-motile and non-infectious
Products: -
?
additional information

?
-
-
Substrates: rhomboid proteases are part of the regulated intramembrane proteolysis mechanism for controlling processes such as development, stress response, lipid metabolism and mitochondrial membrane remodeling
Products: -
?
additional information
?
-
-
Substrates: site-specific serine protease, that cleaves substrates within the vicinity of a transmembrane domain, the cleavage product is then released from the membrane and the other portion is secreted, the enzyme interacts with the plastid translocon component Tic40, overview
Products: -
?
additional information
?
-
-
Substrates: no cleavage of Gurken-transmembrane domain
Products: -
?
additional information
?
-
-
Substrates: the enzyme is important in cell signaling, mechanism, overview
Products: -
?
additional information
?
-
Substrates: the enzyme is involved in regulation of growth factor signaling, mitochondrial fusion, and parasite invasion
Products: -
?
additional information
?
-
Substrates: based on trans-membrane domain of Providencia stuartii TatA as a model substrate a primary recognition motif is identified by a series of deletion analysis. Three positions are particularly sensitive to mutations: P1, P4 and P2'. Whereas P1 tolerates only amino acids with a small side chain, P4 requires large and hydrophobic residues, and P2' prefers hydrophobic side chains irrespective of their size. All other positions between P5 and P2' can tolerate a variety of amino acids, although tryptophan, proline, and aspartate are deleterious in most of them. This recognition motif is functionally conserved in multiple substrates
Products: -
?
additional information
?
-
-
Substrates: Rhomboid is the signal-generating component of epidermal growth factor receptor signaling during development, a metazoan developmental regulator, intramembrane proteolysis is a widespread regulatory mechanism, overview, Rhomboid-3 is important in eye development
Products: -
?
additional information
?
-
-
Substrates: regulation, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in regulation of growth factor signaling, and mitochondrial fusion
Products: -
?
additional information
?
-
-
Substrates: Rhomboid cleaves both type I and type II transmembrane proteins
Products: -
?
additional information
?
-
-
Substrates: structure-function relationship, substrate entry, Rhomboid active-site topology, overview
Products: -
?
additional information
?
-
-
Substrates: no cleavage of EGFR, Delta, TGN38 or TGFalpha
Products: -
?
additional information
?
-
-
Substrates: no cleavage of Gurken-transmembrane domain
Products: -
?
additional information
?
-
-
Substrates: intramembrane proteolysis regulates diverse biological processes
Products: -
?
additional information
?
-
Substrates: the enzyme is involved in regulation of growth factor signaling, mitochondrial fusion, and parasite invasion
Products: -
?
additional information
?
-
Substrates: intramembrane proteolysis is a core regulatory mechanism of cells that raises a biochemical paradox of how hydrolysis of peptide bonds is accomplished within the normally hydrophobic environment of the membrane
Products: -
?
additional information
?
-
-
Substrates: regulation, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme is important in cell signaling, mechanism, overview
Products: -
?
additional information
?
-
Substrates: the enzyme cleave the transmembrane domain of other membrane proteins, membrane topology of a rhomboid protease and its substrate, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme cleave the transmembrane domain of other membrane proteins, membrane topology of a rhomboid protease and its substrate, overview
Products: -
?
additional information
?
-
Substrates: the intramembrane enzyme possesses a intramembraneously located active site, which is accessible to water and hydrolyses an extramembrane peptide bond of substrates, membrane-embedded polypeptide segments of substrates enter at lateral entrance into the enzymes active site
Products: -
?
additional information
?
-
-
Substrates: the intramembrane enzyme possesses a intramembraneously located active site, which is accessible to water and hydrolyses an extramembrane peptide bond of substrates, membrane-embedded polypeptide segments of substrates enter at lateral entrance into the enzymes active site
Products: -
?
additional information
?
-
-
Substrates: structural analysis of the enzyme reveals a gating mechanism for substrate entry, cleavage of substrate peptide bonds within the membrane bilayer, the catalytic Ser201 is located at the N terminus of helix alpha4 approximately 10 A below the membrane surface, structure-function realationship, overview
Products: -
?
additional information
?
-
-
Substrates: structure-function relationship, substrate entry, overview
Products: -
?
additional information
?
-
Substrates: to derive a dynamic view of GlpG in a fluid lipid bilayer, the lipid interactions of GlpG embedded in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPE) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylethanolamine (POPC) lipid bilayers is examined. The irregular shape and small hydrophobic thickness of the protein cause significant bilayer deformations that may be important for substrate entry into the active site. Hydrogen-bond interactions with lipids are paramount in protein orientation and dynamics. Mutations in the unusual L1 loop cause changes in protein dynamics and protein orientation that are relayed to the His-Ser catalytic dyad. Similarly, mutations in TM5 change the dynamics and structure of the L1 loop
Products: -
?
additional information
?
-
-
Substrates: to derive a dynamic view of GlpG in a fluid lipid bilayer, the lipid interactions of GlpG embedded in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPE) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylethanolamine (POPC) lipid bilayers is examined. The irregular shape and small hydrophobic thickness of the protein cause significant bilayer deformations that may be important for substrate entry into the active site. Hydrogen-bond interactions with lipids are paramount in protein orientation and dynamics. Mutations in the unusual L1 loop cause changes in protein dynamics and protein orientation that are relayed to the His-Ser catalytic dyad. Similarly, mutations in TM5 change the dynamics and structure of the L1 loop
Products: -
?
additional information
?
-
Substrates: an artificial fusion protein bearing the sequence around the second transmembrane domain of LacY is cleavable by Escherichia coli GlpG in intact bacterial cells (LacY itself is not a substrate for rhomboid). A Ser-Asp bond is cleaved
Products: -
?
additional information
?
-
Substrates: removal of the cytoplasmic domain does not alter the catalytic parameters for detergent-solubilized rhomboid for both substrates BODIPY FL casein and protein TatA
Products: -
?
additional information
?
-
-
Substrates: removal of the cytoplasmic domain does not alter the catalytic parameters for detergent-solubilized rhomboid for both substrates BODIPY FL casein and protein TatA
Products: -
?
additional information
?
-
-
Substrates: rhomboids may have two different mechanisms for substrate recognition. The transmembrane substrate is recognized on the hydrophobic belt of the enzyme by the exosite, which facilitates the substrate entry laterally into the active site. Soluble substrates, such as FL-casein, do not require initial exosite binding and approach the active site from the soluble face of the enzyme via the opening of loop 5
Products: -
?
additional information
?
-
-
Substrates: the enzyme specifically interacts with phosphatidylethanolamine/phosphatidylglycerol lipids to thin the bilayer at the protein/membrane interface. Phosphatidylethanolamine and phosphatidylglycerol are not specific determinants of enzyme catalytic activity
Products: -
-
additional information
?
-
-
Substrates: GlpG prefers residues with a small side chain and a negative charge at the P1 and P1' sites, respectively, cleavage sites of model substrates and structure function relationship, overview
Products: -
?
additional information
?
-
Substrates: based on trans-membrane domain of Providencia stuartii TatA as a model substrate a primary recognition motif is identified by a series of deletion analysis. Three positions are particularly sensitive to mutations: P1, P4 and P2'. Whereas P1 tolerates only amino acids with a small side chain, P4 requires large and hydrophobic residues, and P2' prefers hydrophobic side chains irrespective of their size. All other positions between P5 and P2' can tolerate a variety of amino acids, although tryptophan, proline, and aspartate are deleterious in most of them. This recognition motif is functionally conserved in multiple substrates
Products: -
?
additional information
?
-
Substrates: regulation, overview
Products: -
?
additional information
?
-
Substrates: structure-function relationship, substrate entry, overview
Products: -
?
additional information
?
-
Substrates: rhomboids may have two different mechanisms for substrate recognition. The transmembrane substrate is recognized on the hydrophobic belt of the enzyme by the exosite, which facilitates the substrate entry laterally into the active site. Soluble substrates, such as FL-casein, do not require initial exosite binding and approach the active site from the soluble face of the enzyme via the opening of loop 5
Products: -
?
additional information
?
-
-
Substrates: rhomboids may have two different mechanisms for substrate recognition. The transmembrane substrate is recognized on the hydrophobic belt of the enzyme by the exosite, which facilitates the substrate entry laterally into the active site. Soluble substrates, such as FL-casein, do not require initial exosite binding and approach the active site from the soluble face of the enzyme via the opening of loop 5
Products: -
?
additional information
?
-
Substrates: rhomboids may have two different mechanisms for substrate recognition. The transmembrane substrate is recognized on the hydrophobic belt of the enzyme by the exosite, which facilitates the substrate entry laterally into the active site. Soluble substrates, such as FL-casein, do not require initial exosite binding and approach the active site from the soluble face of the enzyme via the opening of loop 5
Products: -
?
additional information
?
-
-
Substrates: regulated intramembrane proteolysis in which the putative signaling moiety is part of the intramembrane-cleaving protease itself. Cytosolic N-terminal domain of PARL is cleaved at positions 5253 (alpha-site) and 7778 (beta-site). Whereas alpha-cleavage is constitutive and removes the mitochondrial targeting sequence, beta-cleavage appears to be developmentally controlled and dependent on PARL intramembrane-cleaving protease activity supplied in trans. The beta-cleavage of PARL liberates Pbeta, a nuclear targeted peptide whose sequence is conserved only in mammals. Thus, in addition to its evolutionarily conserved function in regulating mitochondrial dynamics, PARL might mediate a mammalian-specific, developmentally regulated mitochondria-to-nuclei signaling through regulated proteolysis of its N-terminus and release of the Pbeta peptide
Products: -
?
additional information
?
-
-
Substrates: membrane domains of several mammalian EGF-faily proteins are not cleaved by RHBDL2, suggesting that the endogenous targets of the human protease are not EGF-related factors. Amino acid sequence at the luminal face of the membrane domain of a substrate protein determines whether it is cleaved by RHBDL2
Products: -
?
additional information
?
-
-
Substrates: the enzyme is important in cell signaling, mechanism, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in regulation of growth factor signaling, and mitochondrial fusion
Products: -
?
additional information
?
-
-
Substrates: PARL interacts with Alzheimers presenilin protein in vitro
Products: -
?
additional information
?
-
-
Substrates: rhomboid protease RHBDL2 does not cleave transforming growth factor alpha, epiregulin, betacellulin, amphiregulin, heparin binding-epidermal growth factor, vaccinia virus growth factor, transmembrane protein with EGF-like and two follistatin-like domains 2, calnexin, TACE, site-1 protease, neu differentiation factor beta4alpha (Nrg1 isoform), rat glial cell growth factor (Nrg1 isoform), and Nrg4
Products: -
?
additional information
?
-
Substrates: positively charged transmembrane residues promote isoform RHBDL4-catalyzed cleavage
Products: -
?
additional information
?
-
-
Substrates: neither NHK nor an ER-retained mutant of prolactin (Prl-KDEL) are processed by ectopically expressed enzyme RHBDL4
Products: -
-
additional information
?
-
-
Substrates: rhomboid proteases are part of the regulated intramembrane proteolysis mechanism for controlling processes such as development, stress response, lipid metabolism and mitochondrial membrane remodeling
Products: -
?
additional information
?
-
-
Substrates: site-specific serine protease, that cleaves substrates within the vicinity of a transmembrane domain, the cleavage product is then released from the membrane and the other portion is secreted, the enzyme interacts with the plastid translocon component Tic40, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in regulation of growth factor signaling, and mitochondrial fusion
Products: -
?
additional information
?
-
-
Substrates: the two rhomboid proteases ROM1 and ROM4 preferentially cleave different adhesins implicated in all invasive stages of malaria, invasion of host cells by the malaria pathogen relies on parasite transmembrane adhesins that engage host-cell receptors, adhesins must be released by cleavage before the parasite can enter the cell, overview, swapping transmembrane regions between substrates BAEBL and AMA1 switches the relative preferences of ROMs 1 and 4 for these two substrates, no cleavage of adhesin PTRAMP
Products: -
?
additional information
?
-
Substrates: a protease that cleaves the transmembrane regions of proteins involved in parasite invasion
Products: -
?
additional information
?
-
-
Substrates: a protease that cleaves the transmembrane regions of proteins involved in parasite invasion
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in regulation of growth factor signaling, mitochondrial fusion, and parasite invasion
Products: -
?
additional information
?
-
-
Substrates: ROMs 1 and 4 display distinct substrate specificity, overview
Products: -
?
additional information
?
-
Substrates: the enzyme is involved in regulation of growth factor signaling, mitochondrial fusion, and parasite invasion
Products: -
?
additional information
?
-
-
Substrates: the enzyme is important in cell signaling, mechanism, overview
Products: -
?
additional information
?
-
Substrates: based on trans-membrane domain of Providencia stuartii TatA as a model substrate a primary recognition motif is identified by a series of deletion analysis. Three positions are particularly sensitive to mutations: P1, P4 and P2'. Whereas P1 tolerates only amino acids with a small side chain, P4 requires large and hydrophobic residues, and P2' prefers hydrophobic side chains irrespective of their size. All other positions between P5 and P2' can tolerate a variety of amino acids, although tryptophan, proline, and aspartate are deleterious in most of them. This recognition motif is functionally conserved in multiple substrates
Products: -
?
additional information
?
-
Substrates: rhomboids may have two different mechanisms for substrate recognition. The transmembrane substrate is recognized on the hydrophobic belt of the enzyme by the exosite, which facilitates the substrate entry laterally into the active site. Soluble substrates, such as FL-casein, do not require initial exosite binding and approach the active site from the soluble face of the enzyme via the opening of loop 5
Products: -
?
additional information
?
-
-
Substrates: Rhomboids are ubiquitous integral membrane proteases that release cellular signals from membrane-bound substrates through a general signal transduction mechanism known as regulated intramembrane proteolysis
Products: -
?
additional information
?
-
Substrates: the enzyme is involved in regulation of growth factor signaling, mitochondrial fusion, and parasite invasion
Products: -
?
additional information
?
-
-
Substrates: the N-terminal cytosolic domain NRho plays a role in scissile peptide bond selectivity by optimally positioning the Rhomboid active site relative to the membrane plane
Products: -
?
additional information
?
-
-
Substrates: rhomboid proteases are part of the regulated intramembrane proteolysis mechanism for controlling processes such as development, stress response, lipid metabolism and mitochondrial membrane remodeling
Products: -
?
additional information
?
-
-
Substrates: site-specific serine protease, that cleaves substrates within the vicinity of a transmembrane domain, the cleavage product is then released from the membrane and the other portion is secreted, the enzyme interacts with the plastid translocon component Tic40, overview
Products: -
?
additional information
?
-
-
Substrates: rhomboid protease Pcp1 catalyzes the second processing step of cytochrome c peroxidase, yielding the mature cytochrome c peroxidase protein
Products: -
?
additional information
?
-
-
Substrates: intramolecular proteolysis by rhomboids controls cellular processes other than signalling
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in regulation of growth factor signaling, and mitochondrial fusion
Products: -
?
additional information
?
-
-
Substrates: the enzyme is important in cell signaling, mechanism, overview
Products: -
?
additional information
?
-
-
Substrates: no cleavage of Spitz anf Gurken
Products: -
?
additional information
?
-
Substrates: ROM1 does not play a critical role in cell invasion, ROM1-deficient parasites are outcompeted by wild-type Toxoplasma gondii, the ROM1-deficient parasites show only modest decrease in invasion but replicate more slowly than wild-type cells, ROM1 is required for efficient intracellular growth of the parasite, overview
Products: -
?
additional information
?
-
-
Substrates: ROM1 does not play a critical role in cell invasion, ROM1-deficient parasites are outcompeted by wild-type Toxoplasma gondii, the ROM1-deficient parasites show only modest decrease in invasion but replicate more slowly than wild-type cells, ROM1 is required for efficient intracellular growth of the parasite, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme proteolytically cleaves adhesin-receptor complexes during parasite invasion, overview, the enzyme is important in cell sigaling, mechanism, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in regulation of growth factor signaling, mitochondrial fusion, and parasite invasion
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
adhesin BAEBL + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin CTRP + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin EBA-175 + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin JESEBL + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin MAEBL + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin MIC2 + H2O
?
Substrates: -
Products: -
?
adhesin MTRAP + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin PFF0800c + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin Rh1 + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin Rh24 + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin Rh2a + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin Rh2b + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
adhesin TRAP + H2O
?
-
Substrates: substrate of ROM1 and ROM4
Products: -
?
amyloid precursor protein + H2O
?
Substrates: -
Products: -
?
apical membrane antigen 1 + H2O
?
-
Substrates: i.e. AMA1, substrate only of ROM1
Products: -
?
Bcl-2-interacting killer + H2O
?
Substrates: -
Products: -
?
beta-secretase mutant BACE476DELTA + H2O
50 kDa BACE476DELTA fragment + ?
-
Substrates: -
Products: -
?
chaperone Star + H2O
?
-
Substrates: cleavage of Star within its transmembrane domain both in cell culture and in flies, the enzyme is involved in regulation of levels of Spitz, the major Drosophila EGF receptor ligand, mechanism for modulating the activity of Star, thereby influencing the levels of active Spitz ligand, intracellular trafficking of Spitz isimpaired by Rhomboid-dependent cleavage of Star, overview
Products: -
?
cytochrome c peroxidase + H2O
processed cytochrome c peroxidase + targeting sequence peptide
-
Substrates: cleaving the targeting sequence of cytochrome c peroxidase, Pcp1
Products: -
?
ephrin B3 + H2O
?
-
Substrates: RHBDL-2 mediated proteolytic processing may regulate intercellular interactions between ephrinB3 and eph receptors
Products: -
?
epidermal growth factor + H2O
?
-
Substrates: efficient and specific substrate for rhomboid protease RHBDL2
Products: -
?
fatty acid export protein 1 + H2O
?
-
Substrates: the enzyme and fatty acid export protein 1 interact physically at the inner envelope membrane of chloroplasts
Products: -
?
growth factor Spitz + H2O
?
growth-factor gurken + H2O
?
-
Substrates: -
Products: -
?
growth-factor spitz + H2O
?
-
Substrates: -
Products: -
?
Gurken + H2O
?
-
Substrates: -
Products: -
?
Gurken protein + H2O
?
Substrates: -
Products: -
?
Gurken protein + H2O
PQRKVRMA + HIVFSFFV
Gurken-derived peptide + H2O
?
HybA + H2O
?
-
Substrates: physiological substrate of enzyme forms GlpG and Rhom7
Products: -
?
Keren + H2O
?
-
Substrates: -
Products: -
?
Keren protein + H2O
?
-
Substrates: -
Products: -
?
l-Mgm1 + H2O
s-Mgm1 + N-terminal putative transmembrane segment
-
Substrates: rhomboid-type protease Pcp1 is essential for wild type mitochondrial morphology. The processing of the large isoform l-Mgm1 by rhomboid-type protease Pcp1 to s-Mgm1, and the presence of both isoforms of Mgm1 appears to be crucial for wild-type mitochondrial morphology and maintenance of mitochondrial DNA
Products: -
?
LacYTM2 protein + H2O
DINHISKS + DTGIIFAA
large isoform of Mgm1 + H2O
short isoform of Mgm1 + ?
-
Substrates: the enzyme is involved in the pathway of Mgm1 biogenesis. A strong shift in the ratio between both isoform of Mgm1 is sufficient to alter mitochondrial morphology
Products: -
?
lectin + H2O
?
-
Substrates: EhROM1 is able to cleave cell surface lectin
Products: -
?
Mgm1 + H2O
?
-
Substrates: cleaving the long isoform of Mgm1 to produce the short one
Products: -
?
MHC202 + H2O
18 kDa N-terminal MHC202 fragment + ?
-
Substrates: -
Products: -
?
oligosaccharyl transferase + H2O
?
Substrates: -
Products: -
?
Orm2 + H2O
?
-
Substrates: -
Products: -
?
pre T-cell receptor substrate alpha + H2O
?
Substrates: -
Products: -
?
protein Gurken + H2O
?
-
Substrates: -
Products: -
?
protein Keren + H2O
?
-
Substrates: -
Products: -
?
SREBP-1c + H2O
?
-
Substrates: -
Products: -
?
sterol regulatory element-binding protein 1 + H2O
?
Substrates: -
Products: -
?
TatA + H2O
processed TatA + N-terminal extension peptide
TatA protein + H2O
?
Substrates: -
Products: -
?
TatA protein + H2O
MESTIATA + AFGSPWQL
thrombomodulin + H2O
soluble thrombomodulin + ?
-
Substrates: -
Products: -
?
Tic40 + H2O
?
-
Substrates: i.e. the chloroplast inner envelope translocon component of 40 kDa
Products: -
?
tumor suppressor-activated pathway-6 + H2O
?
Substrates: -
Products: -
?
type I membrane protein RPN1 + H2O
?
-
Substrates: -
Products: -
?
additional information
?
-
growth factor Spitz + H2O

?
-
Substrates: -
Products: -
?
growth factor Spitz + H2O
?
-
Substrates: Rhomboid-1 is important in extracellular signal production, overview
Products: -
?
growth factor Spitz + H2O
?
-
Substrates: Rhomboid-1
Products: -
?
Gurken protein + H2O

PQRKVRMA + HIVFSFFV
-
Substrates: -
Products: -
?
Gurken protein + H2O
PQRKVRMA + HIVFSFFV
-
Substrates: -
Products: -
?
Gurken protein + H2O
PQRKVRMA + HIVFSFFV
-
Substrates: -
Products: -
?
Gurken-derived peptide + H2O

?
-
Substrates: -
Products: -
?
Gurken-derived peptide + H2O
?
-
Substrates: -
Products: -
?
LacYTM2 protein + H2O

DINHISKS + DTGIIFAA
-
Substrates: -
Products: -
?
LacYTM2 protein + H2O
DINHISKS + DTGIIFAA
-
Substrates: -
Products: -
?
LacYTM2 protein + H2O
DINHISKS + DTGIIFAA
-
Substrates: -
Products: -
?
MIC adhesin + H2O

?
-
Substrates: only TgRMO5 is able to cleave MIC adhesins, it likely provides the key protease activity necessary for invasion
Products: -
?
MIC adhesin + H2O
?
-
Substrates: only TgRMO5 is able to cleave MIC adhesins, it likely provides the key protease activity necessary for invasion
Products: -
?
MIC adhesin + H2O
?
-
Substrates: only TgRMO5 is able to cleave MIC adhesins, it likely provides the key protease activity necessary for invasion
Products: -
?
MIC adhesin + H2O
?
-
Substrates: only TgRMO5 is able to cleave MIC adhesins, it likely provides the key protease activity necessary for invasion
Products: -
?
MIC adhesin + H2O
?
-
Substrates: only TgRMO5 is able to cleave MIC adhesins, it likely provides the key protease activity necessary for invasion
Products: -
?
MIC adhesin + H2O
?
-
Substrates: only TgRMO5 is able to cleave MIC adhesins, it likely provides the key protease activity necessary for invasion
Products: -
?
protein Spitz + H2O

?
-
Substrates: rhomboids 1-4 are all dedicated to regulating EGF receptor signalling
Products: -
?
protein Spitz + H2O
?
-
Substrates: when Spitz is cleaved by rhomboids in the endoplasmic reticulum it cannot be secreted. Star regulates Spitz cleavage by rhomboid-1 by transporting Spitz to the Golgi apparatus. Rhomboids 1-4 are all dedicated to regulating EGF receptor signalling
Products: -
?
Spitz + H2O

?
-
Substrates: rhomboids 1-4 are all dedicated to regulating EGF receptor signalling
Products: -
?
Spitz + H2O
?
-
Substrates: the rhomboid active site in directly cleaves the membrane-anchored TGFalpha-like growth factor Spitz within its transmembarne domain
Products: -
?
Spitz + H2O
?
-
Substrates: the rhomboid active site in directly cleaves the membrane-anchored TGFalpha-like growth factor Spitz within its transmembarne domain
Products: -
?
Spitz protein + H2O

?
-
Substrates: -
Products: -
?
Spitz protein + H2O
?
-
Substrates: -
Products: -
?
TatA + H2O

processed TatA + N-terminal extension peptide
-
Substrates: rhomboid protease AarA mediates quorum-sensing by activating TatA of the twin-arginine translocase, TatA is a component of the twin-arginine translocase, Tat, protein secretion pathway and likely forms a secretion pore, TatA in Providencia stuartii has a short N-terminal extension, which is proteolytically removed by AarA, overview
Products: -
?
TatA + H2O
processed TatA + N-terminal extension peptide
-
Substrates: rhomboid protease AarA mediates quorum-sensing by activating TatA of the twin-arginine translocase, TatA is a component of the twin-arginine translocase, Tat, protein secretion pathway and likely forms a secretion pore, TatA in Providencia stuartii has a short N-terminal extension, which is proteolytically removed by AarA, overview
Products: -
?
TatA protein + H2O

MESTIATA + AFGSPWQL
-
Substrates: -
Products: -
?
TatA protein + H2O
MESTIATA + AFGSPWQL
-
Substrates: -
Products: -
?
TatA protein + H2O
MESTIATA + AFGSPWQL
-
Substrates: -
Products: -
?
additional information

?
-
-
Substrates: rhomboid proteases are part of the regulated intramembrane proteolysis mechanism for controlling processes such as development, stress response, lipid metabolism and mitochondrial membrane remodeling
Products: -
?
additional information
?
-
-
Substrates: the enzyme is important in cell signaling, mechanism, overview
Products: -
?
additional information
?
-
Substrates: the enzyme is involved in regulation of growth factor signaling, mitochondrial fusion, and parasite invasion
Products: -
?
additional information
?
-
-
Substrates: Rhomboid is the signal-generating component of epidermal growth factor receptor signaling during development, a metazoan developmental regulator, intramembrane proteolysis is a widespread regulatory mechanism, overview, Rhomboid-3 is important in eye development
Products: -
?
additional information
?
-
-
Substrates: regulation, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in regulation of growth factor signaling, and mitochondrial fusion
Products: -
?
additional information
?
-
-
Substrates: intramembrane proteolysis regulates diverse biological processes
Products: -
?
additional information
?
-
Substrates: the enzyme is involved in regulation of growth factor signaling, mitochondrial fusion, and parasite invasion
Products: -
?
additional information
?
-
Substrates: intramembrane proteolysis is a core regulatory mechanism of cells that raises a biochemical paradox of how hydrolysis of peptide bonds is accomplished within the normally hydrophobic environment of the membrane
Products: -
?
additional information
?
-
-
Substrates: regulation, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme is important in cell signaling, mechanism, overview
Products: -
?
additional information
?
-
Substrates: regulation, overview
Products: -
?
additional information
?
-
-
Substrates: regulated intramembrane proteolysis in which the putative signaling moiety is part of the intramembrane-cleaving protease itself. Cytosolic N-terminal domain of PARL is cleaved at positions 5253 (alpha-site) and 7778 (beta-site). Whereas alpha-cleavage is constitutive and removes the mitochondrial targeting sequence, beta-cleavage appears to be developmentally controlled and dependent on PARL intramembrane-cleaving protease activity supplied in trans. The beta-cleavage of PARL liberates Pbeta, a nuclear targeted peptide whose sequence is conserved only in mammals. Thus, in addition to its evolutionarily conserved function in regulating mitochondrial dynamics, PARL might mediate a mammalian-specific, developmentally regulated mitochondria-to-nuclei signaling through regulated proteolysis of its N-terminus and release of the Pbeta peptide
Products: -
?
additional information
?
-
-
Substrates: the enzyme is important in cell signaling, mechanism, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in regulation of growth factor signaling, and mitochondrial fusion
Products: -
?
additional information
?
-
-
Substrates: rhomboid protease RHBDL2 does not cleave transforming growth factor alpha, epiregulin, betacellulin, amphiregulin, heparin binding-epidermal growth factor, vaccinia virus growth factor, transmembrane protein with EGF-like and two follistatin-like domains 2, calnexin, TACE, site-1 protease, neu differentiation factor beta4alpha (Nrg1 isoform), rat glial cell growth factor (Nrg1 isoform), and Nrg4
Products: -
?
additional information
?
-
-
Substrates: rhomboid proteases are part of the regulated intramembrane proteolysis mechanism for controlling processes such as development, stress response, lipid metabolism and mitochondrial membrane remodeling
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in regulation of growth factor signaling, and mitochondrial fusion
Products: -
?
additional information
?
-
-
Substrates: the two rhomboid proteases ROM1 and ROM4 preferentially cleave different adhesins implicated in all invasive stages of malaria, invasion of host cells by the malaria pathogen relies on parasite transmembrane adhesins that engage host-cell receptors, adhesins must be released by cleavage before the parasite can enter the cell, overview, swapping transmembrane regions between substrates BAEBL and AMA1 switches the relative preferences of ROMs 1 and 4 for these two substrates, no cleavage of adhesin PTRAMP
Products: -
?
additional information
?
-
Substrates: a protease that cleaves the transmembrane regions of proteins involved in parasite invasion
Products: -
?
additional information
?
-
-
Substrates: a protease that cleaves the transmembrane regions of proteins involved in parasite invasion
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in regulation of growth factor signaling, mitochondrial fusion, and parasite invasion
Products: -
?
additional information
?
-
Substrates: the enzyme is involved in regulation of growth factor signaling, mitochondrial fusion, and parasite invasion
Products: -
?
additional information
?
-
-
Substrates: the enzyme is important in cell signaling, mechanism, overview
Products: -
?
additional information
?
-
-
Substrates: Rhomboids are ubiquitous integral membrane proteases that release cellular signals from membrane-bound substrates through a general signal transduction mechanism known as regulated intramembrane proteolysis
Products: -
?
additional information
?
-
Substrates: the enzyme is involved in regulation of growth factor signaling, mitochondrial fusion, and parasite invasion
Products: -
?
additional information
?
-
-
Substrates: rhomboid proteases are part of the regulated intramembrane proteolysis mechanism for controlling processes such as development, stress response, lipid metabolism and mitochondrial membrane remodeling
Products: -
?
additional information
?
-
-
Substrates: rhomboid protease Pcp1 catalyzes the second processing step of cytochrome c peroxidase, yielding the mature cytochrome c peroxidase protein
Products: -
?
additional information
?
-
-
Substrates: intramolecular proteolysis by rhomboids controls cellular processes other than signalling
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in regulation of growth factor signaling, and mitochondrial fusion
Products: -
?
additional information
?
-
-
Substrates: the enzyme is important in cell signaling, mechanism, overview
Products: -
?
additional information
?
-
Substrates: ROM1 does not play a critical role in cell invasion, ROM1-deficient parasites are outcompeted by wild-type Toxoplasma gondii, the ROM1-deficient parasites show only modest decrease in invasion but replicate more slowly than wild-type cells, ROM1 is required for efficient intracellular growth of the parasite, overview
Products: -
?
additional information
?
-
-
Substrates: ROM1 does not play a critical role in cell invasion, ROM1-deficient parasites are outcompeted by wild-type Toxoplasma gondii, the ROM1-deficient parasites show only modest decrease in invasion but replicate more slowly than wild-type cells, ROM1 is required for efficient intracellular growth of the parasite, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme proteolytically cleaves adhesin-receptor complexes during parasite invasion, overview, the enzyme is important in cell sigaling, mechanism, overview
Products: -
?
additional information
?
-
-
Substrates: the enzyme is involved in regulation of growth factor signaling, mitochondrial fusion, and parasite invasion
Products: -
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
(3S,4S)-1-[(4-chlorophenyl)sulfonyl]-3-methyl-4-phenylazetidin-2-one
(3S,4S)-3-butyl-4-(pent-4-yn-1-yl)oxetan-2-one
-
-
(3S,4S)-3-methyl-1-[(4-methylphenyl)sulfonyl]-4-phenylazetidin-2-one
-
-
1,2-dihexanoyl-sn-glycero-3-phosphocholine
-
1,2-dimyristoyl-sn-glycero-3-phosphocholine additionally added, paGlpG purified in detergent causes 37% reduction in activity
1,2-dimyristoyl-sn-glycero-3-phosphocholine
-
paGlpG purified in detergent causes 5% reduction in activity
1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3,3,3-trifluoro-2-(trifluoromethyl)propan-1-one
1-(4-[[4-(4-bromophenyl)piperazin-1-yl]methyl]phenyl)-3,3-diethylazetidine-2,4-dione
-
1-(biphenyl-3-ylsulfonyl)-4-phenylazetidin-2-one
1-(biphenyl-4-ylsulfonyl)-4-phenylazetidin-2-one
1-myristoyl-sn-glycero-3-phosphocholine
-
paGlpG purified in detergent causes 10% reduction in activity
1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol)
-
paGlpG purified in detergent causes 20% reduction in activity
1-[(3'-methylbiphenyl-4-yl)sulfonyl]-4-phenylazetidin-2-one
1-[(3-bromophenyl)sulfonyl]-4-phenylazetidin-2-one
1-[(3-chlorophenyl)sulfonyl]-4-(2-phenylethyl)azetidin-2-one
1-[(3-chlorophenyl)sulfonyl]-4-(propan-2-yl)azetidin-2-one
1-[(4'-chlorobiphenyl-4-yl)sulfonyl]-4-phenylazetidin-2-one
1-[(4-bromophenyl)sulfonyl]-4-phenylazetidin-2-one
1-[(4-chlorophenyl)sulfonyl]-3-methylazetidin-2-one
1-[(4-methylphenyl)sulfonyl]-4-phenylazetidin-2-one
1-[2-([4-[(4-bromophenyl)methyl]piperazin-1-yl]methyl)phenyl]-3,3-diethylazetidine-2,4-dione
-
1-[3-([4-[(4-bromophenyl)methyl]piperazin-1-yl]methyl)phenyl]-3,3-diethylazetidine-2,4-dione
-
1-[4-([4-[(4-bromophenyl)methyl]piperazin-1-yl]methyl)phenyl]-3,3-diethylazetidine-2,4-dione
-
2-(benzyloxy)-5-chloro-4H-3,1-benzoxazin-4-one
2-(benzyloxy)-5-methyl-4H-3,1-benzoxazin-4-one
2-methylpropyl 2-oxo-4-phenylazetidine-1-carboxylate
beta-lactam inhibitor, forms a single bond to the catalytic serine and the carbonyl oxygen of the inhibitor faces away from the oxyanion hole. The hydrophobic N-substituent of the inhibitor points into a cavity within the enzyme, providing a structural explanation for the specificity of beta-lactams on rhomboid proteases. This same cavity probably represents the S2' substrate binding site
3,3,3-trifluoro-N-[(5-methyl-2-phenyl-2H-1,2,3-triazol-4-yl)methyl]-2-(trifluoromethyl)propanamide
3,3,3-trifluoro-N-[2-(propan-2-yloxy)phenyl]-2-(trifluoromethyl)propanamide
3,3-diethyl-1-(4-[[4-(prop-2-yn-1-yl)piperazin-1-yl]methyl]phenyl)azetidine-2,4-dione
-
3,4-dichloro-1H-2-benzopyran-1-one
-
-
3-butyl-4-(pent-4-yn-1-yl)oxetan-2-one
-
3-methyl-1-[(4-methylphenyl)sulfonyl]-4-phenylazetidin-2-one
-
-
3-[(3-cholamidopropyl)-dimethylammonio]-1-propansulfonate
-
1,2-dimyristoyl-sn-glycero-3-phosphocholine additionally added, paGlpG purified in detergent causes 37% reduction in activity
4-(2-chlorophenyl)-1-[(3-chlorophenyl)sulfonyl]azetidin-2-one
4-(3-bromophenyl)-1-[(3-chlorophenyl)sulfonyl]azetidin-2-one
4-chloro-7-nitro-3-[(5-phenylpentyl)oxy]-1H-2-benzopyran-1-one
inhibitor reacts with virtually all tested rhomboids
4-[(3-methyl-2-oxoazetidin-1-yl)sulfonyl]benzonitrile
7-amino-3-butoxy-4-chloro-1H-isochromen-1-one
-
7-amino-3-butynoxy-4-chloro-isocoumarin
S006, irreversible inhibitor
-
7-amino-4-chloro-3-(2-phenylethoxy)-1H-isochromen-1-one
-
7-amino-4-chloro-3-methoxyisocoumarin
-
7-amino-4-chloro-3-[(5-phenylpentyl)oxy]-1H-isochromen-1-one
-
acetyl-AVFLA-N-(4-phenylbutyl)formamide
-
-
-
acetyl-L-Ile-L-Ala-L-Thr-L-Ala-chloromethylketone
-
inhibitor derived from the natural rhomboid substrate TatA from bacterium Providencia stuartii, binds in a substrate-like manner
acetyl-L-Phe-L-Ala-L-Thr-L-Ala-chloromethylketone
-
inhibitor derived from the natural rhomboid substrate TatA from bacterium Providencia stuartii, binds in a substrate-like manner
acetyl-RRAVFLA-N-(4-phenylbutyl)formamide
-
-
-
acetyl-RRFKIF-N-(4-phenylbutyl)formamide
-
-
-
acetyl-VRHA-N-(4-phenylbutyl)formamide
-
-
-
benzyl (2S)-1-[(4-methylphenyl)sulfonyl]-4-oxoazetidine-2-carboxylate
cyclopentyl 2-oxo-4-phenylazetidine-1-carboxylate
beta-lactam inhibitor, forms a single bond to the catalytic serine and the carbonyl oxygen of the inhibitor faces away from the oxyanion hole. The hydrophobic N-substituent of the inhibitor points into a cavity within the enzyme, providing a structural explanation for the specificity of beta-lactams on rhomboid proteases. This same cavity probably represents the S2' substrate binding site
diisopropyl fluorophosphonate
irreversible inhibition; mechansim-based inhibitor
dodecyl maltoside
-
paGlpG purified in detergent causes 77% reduction in activity
N-(2,6-dimethylphenyl)-3,3,3-trifluoro-2-(trifluoromethyl)propanamide
n-nonyl-beta-D-glucoside
-
paGlpG purified in detergent causes 45% reduction in activity
N-[2-(cyclopentyloxy)phenyl]-3,3,3-trifluoro-2-(trifluoromethyl)propanamide
N-[2-(cyclopropylmethoxy)phenyl]-3,3,3-trifluoro-2-(trifluoromethyl)propanamide
phenyl 2-oxo-4-phenylazetidine-1-carboxylate
tert-butyl 2-[[3,3,3-trifluoro-2-(trifluoromethyl)propanoyl]amino]benzoate
(3S,4S)-1-[(4-chlorophenyl)sulfonyl]-3-methyl-4-phenylazetidin-2-one

-
-
(3S,4S)-1-[(4-chlorophenyl)sulfonyl]-3-methyl-4-phenylazetidin-2-one
-
-
1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3,3,3-trifluoro-2-(trifluoromethyl)propan-1-one

-
-
1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3,3,3-trifluoro-2-(trifluoromethyl)propan-1-one
-
-
1-(biphenyl-3-ylsulfonyl)-4-phenylazetidin-2-one

-
-
1-(biphenyl-3-ylsulfonyl)-4-phenylazetidin-2-one
-
-
1-(biphenyl-4-ylsulfonyl)-4-phenylazetidin-2-one

-
-
1-(biphenyl-4-ylsulfonyl)-4-phenylazetidin-2-one
-
-
1-[(3'-methylbiphenyl-4-yl)sulfonyl]-4-phenylazetidin-2-one

-
-
1-[(3'-methylbiphenyl-4-yl)sulfonyl]-4-phenylazetidin-2-one
-
-
1-[(3-bromophenyl)sulfonyl]-4-phenylazetidin-2-one

-
-
1-[(3-bromophenyl)sulfonyl]-4-phenylazetidin-2-one
-
-
1-[(3-chlorophenyl)sulfonyl]-4-(2-phenylethyl)azetidin-2-one

-
-
1-[(3-chlorophenyl)sulfonyl]-4-(2-phenylethyl)azetidin-2-one
-
-
1-[(3-chlorophenyl)sulfonyl]-4-(propan-2-yl)azetidin-2-one

-
-
1-[(3-chlorophenyl)sulfonyl]-4-(propan-2-yl)azetidin-2-one
-
-
1-[(4'-chlorobiphenyl-4-yl)sulfonyl]-4-phenylazetidin-2-one

-
-
1-[(4'-chlorobiphenyl-4-yl)sulfonyl]-4-phenylazetidin-2-one
-
-
1-[(4-bromophenyl)sulfonyl]-4-phenylazetidin-2-one

-
-
1-[(4-bromophenyl)sulfonyl]-4-phenylazetidin-2-one
-
-
1-[(4-chlorophenyl)sulfonyl]-3-methylazetidin-2-one

-
-
1-[(4-chlorophenyl)sulfonyl]-3-methylazetidin-2-one
-
-
1-[(4-methylphenyl)sulfonyl]-4-phenylazetidin-2-one

-
-
1-[(4-methylphenyl)sulfonyl]-4-phenylazetidin-2-one
-
-
2-(benzyloxy)-5-chloro-4H-3,1-benzoxazin-4-one

-
covalent, but slow reversible inhibition mechanism
2-(benzyloxy)-5-chloro-4H-3,1-benzoxazin-4-one
-
covalent, but slow reversible inhibition mechanism
2-(benzyloxy)-5-methyl-4H-3,1-benzoxazin-4-one

-
covalent, but slow reversible inhibition mechanism
2-(benzyloxy)-5-methyl-4H-3,1-benzoxazin-4-one
-
covalent, but slow reversible inhibition mechanism
3,3,3-trifluoro-N-[(5-methyl-2-phenyl-2H-1,2,3-triazol-4-yl)methyl]-2-(trifluoromethyl)propanamide

-
-
3,3,3-trifluoro-N-[(5-methyl-2-phenyl-2H-1,2,3-triazol-4-yl)methyl]-2-(trifluoromethyl)propanamide
-
-
3,3,3-trifluoro-N-[2-(propan-2-yloxy)phenyl]-2-(trifluoromethyl)propanamide

-
-
3,3,3-trifluoro-N-[2-(propan-2-yloxy)phenyl]-2-(trifluoromethyl)propanamide
-
-
3,4-dichloroisocoumarin

-
-
3,4-dichloroisocoumarin
-
3,4-dichloroisocoumarin
mechanism-based inhibitor
3,4-dichloroisocoumarin
-
-
4-(2-chlorophenyl)-1-[(3-chlorophenyl)sulfonyl]azetidin-2-one

-
-
4-(2-chlorophenyl)-1-[(3-chlorophenyl)sulfonyl]azetidin-2-one
-
-
4-(3-bromophenyl)-1-[(3-chlorophenyl)sulfonyl]azetidin-2-one

-
-
4-(3-bromophenyl)-1-[(3-chlorophenyl)sulfonyl]azetidin-2-one
-
-
4-[(3-methyl-2-oxoazetidin-1-yl)sulfonyl]benzonitrile

-
-
4-[(3-methyl-2-oxoazetidin-1-yl)sulfonyl]benzonitrile
-
-
benzyl (2S)-1-[(4-methylphenyl)sulfonyl]-4-oxoazetidine-2-carboxylate

-
-
benzyl (2S)-1-[(4-methylphenyl)sulfonyl]-4-oxoazetidine-2-carboxylate
-
-
dichloroisocoumarin

-
below 0.1 mM
dichloroisocoumarin
-
below 0.1 mM
dichloroisocoumarin
-
below 0.1 mM
dichloroisocoumarin
-
below 0.1 mM
N-(2,6-dimethylphenyl)-3,3,3-trifluoro-2-(trifluoromethyl)propanamide

-
-
N-(2,6-dimethylphenyl)-3,3,3-trifluoro-2-(trifluoromethyl)propanamide
-
-
N-[2-(cyclopentyloxy)phenyl]-3,3,3-trifluoro-2-(trifluoromethyl)propanamide

-
-
N-[2-(cyclopentyloxy)phenyl]-3,3,3-trifluoro-2-(trifluoromethyl)propanamide
-
-
N-[2-(cyclopropylmethoxy)phenyl]-3,3,3-trifluoro-2-(trifluoromethyl)propanamide

-
-
N-[2-(cyclopropylmethoxy)phenyl]-3,3,3-trifluoro-2-(trifluoromethyl)propanamide
-
-
phenyl 2-oxo-4-phenylazetidine-1-carboxylate

-
-
phenyl 2-oxo-4-phenylazetidine-1-carboxylate
beta-lactam inhibitor, forms a single bond to the catalytic serine and the carbonyl oxygen of the inhibitor faces away from the oxyanion hole. The hydrophobic N-substituent of the inhibitor points into a cavity within the enzyme, providing a structural explanation for the specificity of beta-lactams on rhomboid proteases. This same cavity probably represents the S2' substrate binding site
phenyl 2-oxo-4-phenylazetidine-1-carboxylate
-
-
tert-butyl 2-[[3,3,3-trifluoro-2-(trifluoromethyl)propanoyl]amino]benzoate

-
-
tert-butyl 2-[[3,3,3-trifluoro-2-(trifluoromethyl)propanoyl]amino]benzoate
-
-
additional information

-
no inhibition by EDTA, o-phenanthroline, E64, PMSF, 4-(2-aminoethyl)benzenesulfonyl fluoride and pepstatin A
-
additional information
-
no inhibition by EDTA, o-phenanthroline, E64, PMSF, 4-(2-aminoethyl)benzenesulfonyl fluoride and pepstatin A
-
additional information
-
an alkoxy substituent at the 2-position of enzoxazin-4-one inhibitors is crucial for potency and results in low micromolar inhibitors of rhomboid proteases
-
additional information
-
no inhibition by EDTA, o-phenanthroline, E64, PMSF, 4-(2-aminoethyl)benzenesulfonyl fluoride and pepstatin A
-
additional information
local perturbations around the active site hinder proteolytic activity
-
additional information
identification of beta-lactone inhititors that form covalent and irreversible complexes with the active site serine of GlpG. The presence of alkyne handles on the beta-lactones also allows activity-based labeling
-
additional information
-
identification of beta-lactone inhititors that form covalent and irreversible complexes with the active site serine of GlpG. The presence of alkyne handles on the beta-lactones also allows activity-based labeling
-
additional information
comparison of the inhibitory capacity of 50 small molecules against 13 different rhomboids unsing activity-based protein profiling. Inhibition profile and sequence similarity of rhomboids are not related, which suggests that related rhomboids may be selectively inhibited
-
additional information
-
comparison of the inhibitory capacity of 50 small molecules against 13 different rhomboids unsing activity-based protein profiling. Inhibition profile and sequence similarity of rhomboids are not related, which suggests that related rhomboids may be selectively inhibited
-
additional information
-
an alkoxy substituent at the 2-position of enzoxazin-4-one inhibitors is crucial for potency and results in low micromolar inhibitors of rhomboid proteases
-
additional information
-
inhibitor profiles of rhomboids in micelles and liposomes are similar
-
additional information
-
no inhibition by EDTA, o-phenanthroline, E64, PMSF, 4-(2-aminoethyl)benzenesulfonyl fluoride and pepstatin A
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.07
(3S,4S)-1-[(4-chlorophenyl)sulfonyl]-3-methyl-4-phenylazetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.029 - 0.044
(3S,4S)-3-butyl-4-(pent-4-yn-1-yl)oxetan-2-one
0.03
(3S,4S)-3-methyl-1-[(4-methylphenyl)sulfonyl]-4-phenylazetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.0038
1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3,3,3-trifluoro-2-(trifluoromethyl)propan-1-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.00048
1-(4-[[4-(4-bromophenyl)piperazin-1-yl]methyl]phenyl)-3,3-diethylazetidine-2,4-dione
Escherichia coli
at pH 7.5 and 37°C
0.014
1-(biphenyl-3-ylsulfonyl)-4-phenylazetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.041
1-(biphenyl-4-ylsulfonyl)-4-phenylazetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.043
1-[(3'-methylbiphenyl-4-yl)sulfonyl]-4-phenylazetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.016
1-[(3-bromophenyl)sulfonyl]-4-phenylazetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.033
1-[(3-chlorophenyl)sulfonyl]-4-(2-phenylethyl)azetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.085
1-[(3-chlorophenyl)sulfonyl]-4-(propan-2-yl)azetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.047
1-[(4'-chlorobiphenyl-4-yl)sulfonyl]-4-phenylazetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.026
1-[(4-bromophenyl)sulfonyl]-4-phenylazetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.026
1-[(4-chlorophenyl)sulfonyl]-3-methylazetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.074
1-[(4-methylphenyl)sulfonyl]-4-phenylazetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.0065
1-[3-([4-[(4-bromophenyl)methyl]piperazin-1-yl]methyl)phenyl]-3,3-diethylazetidine-2,4-dione
Escherichia coli
at pH 7.5 and 37°C
0.0039
1-[4-([4-[(4-bromophenyl)methyl]piperazin-1-yl]methyl)phenyl]-3,3-diethylazetidine-2,4-dione
Escherichia coli
at pH 7.5 and 37°C
0.001 - 0.015
2-(benzyloxy)-5-methyl-4H-3,1-benzoxazin-4-one
0.0033
3,3,3-trifluoro-N-[(5-methyl-2-phenyl-2H-1,2,3-triazol-4-yl)methyl]-2-(trifluoromethyl)propanamide
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.0023
3,3,3-trifluoro-N-[2-(propan-2-yloxy)phenyl]-2-(trifluoromethyl)propanamide
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.0056 - 0.019
3,4-dichloro-1H-2-benzopyran-1-one
0.044
3-butyl-4-(pent-4-yn-1-yl)oxetan-2-one
Escherichia coli
pH not specified in the publication, temperature not specified in the publication
0.0183
4-(2-chlorophenyl)-1-[(3-chlorophenyl)sulfonyl]azetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.0068
4-(3-bromophenyl)-1-[(3-chlorophenyl)sulfonyl]azetidin-2-one
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.02
4-[(3-methyl-2-oxoazetidin-1-yl)sulfonyl]benzonitrile
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.0004
7-amino-3-butoxy-4-chloro-1H-isochromen-1-one
Escherichia coli
pH 7.3, 37°C
0.0011
7-amino-4-chloro-3-(2-phenylethoxy)-1H-isochromen-1-one
Escherichia coli
pH 7.3, 37°C
0.006
7-amino-4-chloro-3-methoxyisocoumarin
Escherichia coli
in 50 mM HEPES-NaOH (pH 7.5), 0.4 M NaCl, 5 mM EDTA, 10% (v/v) glycerol, and 0.05% (w/v) n-dodecyl-beta-D-maltoside, at 37°C
0.00075
7-amino-4-chloro-3-[(5-phenylpentyl)oxy]-1H-isochromen-1-one
Escherichia coli
pH 7.3, 37°C
0.000028 - 0.00041
acetyl-AVFLA-N-(4-phenylbutyl)formamide
-
0.00008 - 0.0032
acetyl-RRAVFLA-N-(4-phenylbutyl)formamide
-
0.001042
acetyl-RRFKIF-N-(4-phenylbutyl)formamide
Escherichia coli
-
with acetyl-RRRAVFLA-7-amido-4-methyl-2H-1-benzopyran-2-one as substrate, at pH 7.4 and 37°C
-
0.000132
acetyl-VRHA-N-(4-phenylbutyl)formamide
Escherichia coli
-
with acetyl-RRRAVFLA-7-amido-4-methyl-2H-1-benzopyran-2-one as substrate, at pH 7.4 and 37°C
-
0.029
benzyl (2S)-1-[(4-methylphenyl)sulfonyl]-4-oxoazetidine-2-carboxylate
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.017
N-(2,6-dimethylphenyl)-3,3,3-trifluoro-2-(trifluoromethyl)propanamide
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.0018
N-[2-(cyclopentyloxy)phenyl]-3,3,3-trifluoro-2-(trifluoromethyl)propanamide
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.001
N-[2-(cyclopropylmethoxy)phenyl]-3,3,3-trifluoro-2-(trifluoromethyl)propanamide
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.182
phenyl 2-oxo-4-phenylazetidine-1-carboxylate
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.0013
tert-butyl 2-[[3,3,3-trifluoro-2-(trifluoromethyl)propanoyl]amino]benzoate
Providencia stuartii
-
25 mM HEPES, pH 7.4, 5 mM EDTA, 5% (v/v) glycerol, 0.5% (w/v) DDM, 20% (v/v) DMSO, at 25°C
0.029
(3S,4S)-3-butyl-4-(pent-4-yn-1-yl)oxetan-2-one

Escherichia coli
-
enzyme reconstituted in liposome, pH not specified in the publication, temperature not specified in the publication
0.044
(3S,4S)-3-butyl-4-(pent-4-yn-1-yl)oxetan-2-one
Escherichia coli
-
enzyme reconstituted in micelle, pH not specified in the publication, temperature not specified in the publication
0.001
2-(benzyloxy)-5-methyl-4H-3,1-benzoxazin-4-one

Escherichia coli
-
pH not specified in the publication, temperature not specified in the publication
0.0012
2-(benzyloxy)-5-methyl-4H-3,1-benzoxazin-4-one
Escherichia coli
-
pH not specified in the publication, temperature not specified in the publication
0.0016
2-(benzyloxy)-5-methyl-4H-3,1-benzoxazin-4-one
Bacillus subtilis
-
pH not specified in the publication, temperature not specified in the publication
0.015
2-(benzyloxy)-5-methyl-4H-3,1-benzoxazin-4-one
Bacillus subtilis
-
pH not specified in the publication, temperature not specified in the publication
0.0056
3,4-dichloro-1H-2-benzopyran-1-one

Escherichia coli
-
enzyme reconstituted in liposome, pH not specified in the publication, temperature not specified in the publication
0.019
3,4-dichloro-1H-2-benzopyran-1-one
Escherichia coli
-
enzyme reconstituted in micelle, pH not specified in the publication, temperature not specified in the publication
0.000028
acetyl-AVFLA-N-(4-phenylbutyl)formamide

Escherichia coli
-
with acetyl-RRRAVFLA-7-amido-4-methyl-2H-1-benzopyran-2-one as substrate, at pH 7.4 and 37°C
-
0.00041
acetyl-AVFLA-N-(4-phenylbutyl)formamide
Escherichia coli
-
with PGAM5 as substrate, at pH 7.4 and 37°C
-
0.00008
acetyl-RRAVFLA-N-(4-phenylbutyl)formamide

Escherichia coli
-
with acetyl-RRRAVFLA-7-amido-4-methyl-2H-1-benzopyran-2-one as substrate, at pH 7.4 and 37°C
-
0.0032
acetyl-RRAVFLA-N-(4-phenylbutyl)formamide
Escherichia coli
-
with PGAM5 as substrate, at pH 7.4 and 37°C
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
malfunction

-
muscle knockdown of PARL in mice results in malformed mitochondrial cristae, lower mitochondrial content, decreased PGC1alpha protein levels, and impaired insulin signaling. Suppression of PARL protein in healthy myotubes lowers mitochondrial mass and insulin-stimulated glycogen synthesis and increases reactive oxygen species production
malfunction
-
rhomboid is required for pattern formation in the ventral ectoderm, in which mutation causes a rhomboid-shaped head skeleton. This phenotype is due to the role of fly rhomboid in epidermal growth factor receptor signaling
malfunction
-
functional studies in vivo have shown that approximately 90% of Rho-7 mutant flies that lack the transcriptional start site and the first 18 codons of the protease die before pupariation
malfunction
-
ablation of Pcp1/Rbd1 activity has a profound effect on mitochondrial shape. Phenotype observed in Pcp1 knockout cells appears to be due to the selective loss of Mgm1p processing by Pcp1
malfunction
-
mice null for Parl do not show embryonic lethality and synaptic defects are not observed. Mice lacking Parl die between weeks 8 and 12 from cachexia sustained by multisystemic atrophy. Mitochondrial morphology and oxidative phosphorylation is not changed as seen in yeast knockout cells. Parl knockout cells are more susceptible to apoptosis
malfunction
-
mice null for Parl do not show embryonic lethality and synaptic defects are not observed
malfunction
-
loss of rhomboid blocks the induction of rhodopsin5 expression and misexpression of rhomboid leads to the inappropriate induction of rhodopsin5. Activated Epidermal Growth Factor Receptor is is sufficient to rescue the loss of Rh5 induction in a rhomboid mutant
malfunction
-
using optical coherence tomography to examine the cardiac function in adult Drosophila from a set of molecularly defined genomic deficiencies an abnormally enlarged cardiac chamber in a series of deficiency mutants spanning the rhomboid 3 locus are identified. It is demonstrated that rhomboid 3 mediated activation of the EGF receptor pathway is necessary for proper adult cardiac function
malfunction
-
whereas wild-type Plasmodium berghei is lethal to mice, animals infected with PbROM1 null mutants clear the parasites efficiently and develop long-lasting protective immunity
malfunction
suppression of TgROM4 leads to decreased release of the adhesin MIC2 into the supernatant and concomitantly increases the surface expression of this and a subset of other adhesins. Suppression of TgROM4 results in disruption of normal gliding, with the majority of parasites twirling on their posterior ends. Parasites lacking TgROM4 bind better to host cells, but lose the ability to apically orient therefore invasion is severely impaired
malfunction
-
inhibition of RHBDL2 by 3,4-dichloroisocoumarin or short hairpin RNA significantly inhibits wound-induced thrombomodulin ectodomain shedding and wound healing
malfunction
-
mice lacking isoform RHBDL4 are sensitive to endoplasmic reticulum stress and develop liver steatosis
malfunction
-
enzyme gene deletion has no obvious effect in Brucella abortus virulence
malfunction
-
enzyme mutants exhibit impaired frost tolerance
malfunction
-
enzyme gene deletion ameliorates lipid accumulation by Western diet
malfunction
Enzyme loop 1 retrotranslocation-deficient mutants are unable to bind endoplasmic reticulum membrane substrates. Enzyme transmembrane domain 2 mutants disrupt lipid thinning activity
malfunction
-
Enzyme loop 1 retrotranslocation-deficient mutants are unable to bind endoplasmic reticulum membrane substrates. Enzyme transmembrane domain 2 mutants disrupt lipid thinning activity
malfunction
-
enzyme gene deletion has no obvious effect in Brucella abortus virulence
-
metabolism

-
the RHBDL4-SREBP-1c pathway reveals a regulatory system for monitoring fatty acid composition and maintaining cellular lipid homeostasis
metabolism
-
the enzyme cleaves aggregation-prone endoplasmic reticulum-luminal proteins, initiating degradation by an endoplasmic reticulum-associated degradation pathway parallel to Hrd1-dependent retrotranslocation
metabolism
-
the enzyme associates with the SPOTS complex, which is composed of serine palmitoyltransferase enzymes and accessory components that are critical for catalyzing the first rate-limiting step of the sphingolipid biosynthesis pathway. Furthermore, the enzyme employs an endoplasmic reticulum-associated degradation-independent role for facilitating the endoplasmic reticulum export and endosome- and Golgi-associated degradation of Orm2, which is a major antagonist of serine palmitoyltransferase activity
physiological function

-
the cytosolic domain does not interact with the lipid membrane, but instead enhances rhomboid activity through interactions with some other part of the rhomboid, such as the catalytic core domain
physiological function
-
studies in bacteria and Drosophila show that RHO subfamily members Aar from Providencia stuarti and Rho-1 from Drosophila melanogaster can functionally complement each other
physiological function
-
studies in bacteria and Drosophila show that RHO subfamily members Aar from Providencia stuarti and Rho-1 from Drosophila melanogaster can functionally complement each other. Expression of Aar triggers EGFR signaling when expressed in flies
physiological function
-
studies in bacteria and Drosophila show that RHO subfamily members Aar from Providencia stuarti and Rho-1 from Drosophila melanogaster can functionally complement each other. Expression of Aar triggers EGFR signaling when expressed in flies
physiological function
-
studies in bacteria and Drosophila show that RHO subfamily members Aar from Providencia stuarti and Rho-1 from Drosophila melanogaster can functionally complement each other. Expression of Aar triggers EGFR signaling when expressed in flies
physiological function
-
studies in bacteria and Drosophila show that RHO subfamily members Aar from Providencia stuarti and Rho-1 from Drosophila melanogaster can functionally complement each other. Expression of Aar triggers EGFR signaling when expressed in flies
physiological function
studies in bacteria and Drosophila show that RHO subfamily members Aar from Providencia stuarti and Rho-1 from Drosophila melanogaster can functionally complement each other
physiological function
-
Parl is required to regulate the kinetics of cytochrome c release from mitochondria
physiological function
-
16 SNPs are identified in 1086 Caucasian individuals. Statistical genetic analysis reveal that one promoter variant, T-191C, exhibit significant effects on mitochondrial content levels. Comparison of the transcription factor binding characteristics of the T-191C promoter SNP by EMSA indicates preferential binding of nuclear factors to the T allele, suggesting functional variation in PARL expression
physiological function
-
rhomboid is required cell-autonomously within the R8 photoreceptor cells and non-autonomously elsewhere in the eye for rhodopsin5 induction
physiological function
-
PbROM1 functions in the invasive stages of parasite development
physiological function
TgROM4 is involved in shedding of micronemal proteins from the cell surface. Down regulation of TgROM4 disrupts the normal apical-posterior gradient of adhesins that is important for efficient cell motility and invasion of host cells by Toxoplasma gondii
physiological function
-
the rhomboid protease RHBDL2 cleaves epidermal growth factor outside its transmembrane domain, thereby facilitating its secretion and triggering activation of the epidermal growth factor receptor. RHBDL2 regulates ADAM-independent epidermal growth factor secretion
physiological function
-
RHBDL2 is required for wound recovery, cell migration, and proliferation
physiological function
rhomboid pseudoprotease Derlin-1 is required for the dislocation of mutant alpha-1 antitrypsin from the endoplasmic reticulum
physiological function
-
isoform RBL10 may function in the heat-shock response pathway, isoform RBL5 may function in reproductive organs maturation, isoform RBL2 in pollen elongation, isoform RBL7 in embryo development, isoform RBL11 in senescence and isoform RBL6 may be involved in response to abiotic stimuli
physiological function
mutant plants lacking rhomboid-like protein 10 demonstrate reduced fertility, along with abberrant floral morphology
physiological function
deletion of isoform ROM4 blocks the shedding of adhesins such as MIC2 (microneme protein 2), causing them to accumulate on the surface of extracellular parasites. Increased surface adhesins lead to nonproductive attachment, altered gliding motility, impaired moving junction formation, and reduced invasion efficiency. ROM4 is the primary protease involved in adhesin processing and host cell invasion. Triple mutants lacking all isoforms ROM1/ROM4/ROM5 are viable and MIC2 is still efficiently removed from the surface of invaded mutant parasites, implying the existence of ROM-independent mechanisms for adhesin removal during invasion
physiological function
isoform RHBDL4 is a ubiquitin-dependent ER-resident intramembrane protease that is upregulated upon ER stress. RHBDL4 cleaves single-spanning and polytopic membrane proteins with unstable transmembrane helices, leading to their degradation by the canonical ER-associated degradation machinery and binds ubiquitin in Its conserved C-terminal domain. RHBDL4 specifically binds the AAA+-ATPase p97
physiological function
both isoforms ROM4 and ROM5 are dispensable for parasite survival. Shedding of micronemal proteins and invasion are not altered in the absence of ROM5, but this protease is responsible for the residual cleavage of apical membrane antigen AMA1, is able to cleave other apical membrane antigen family members and exhibits a detectable contribution to invasion in the absence of ROM4
physiological function
parasites lacking isoform ROM4 predominantly engage in twirling motility and exhibit enhanced attachment and impaired invasion, whereas intracellular growth and egress are not affected. The substrates microneme proteins MIC2 and MIC6 are not cleaved and accumulate on the rom4 -knockout parasite surface
physiological function
a gene deletion mutant shows reduced motility and increased sensitivity to novobiocin. Mutant membrane preparations are enriched in glycoproteins S-layer glycoprotein and an ABC transporter component. The mutant S-layer glycoprotein contains the oligosaccharide GlcNAc2(Hex)2-6-deoxy-6-sulfoglucose-Hex-6-deoxy-6-sulfoglucose bound to residue N732, while the wild type glycoprotein releases the oligosaccharide species GlcNAc-GlcNAc(Hex)2-(6-deoxy-6-sulfoglucose)-Hex6
physiological function
rhomboid displays a rapid diffusion comparable to the diffusion of small, single-pass transmembrane proteins, with a diffusion coefficient of about 0.8 microm2 per s. The rhomboid fold is able to distort surrounding lipids, overcome the viscosity limit of the membrane, and accelerate its search for substrates
physiological function
-
rhomboid displays a rapid diffusion comparable to the diffusion of small, single-pass transmembrane proteins, with a diffusion coefficient of about 0.8 microm2 per s. The rhomboid fold is able to distort surrounding lipids, overcome the viscosity limit of the membrane, and accelerate its search for substrates
physiological function
deleting the amino-terminal EF-hands activates proteolysis prematurely. Residues in cytoplasmic loops connecting distal transmembrane segments mediate calcium stimulation. Presence of calcium increases catalytic rate by promoting substrate gating. Substrates with cleavage sites outside the membrane can be cleaved but lose the capacity to be regulated
physiological function
the enzyme plays a role in the endoplasmic reticulum-associated degradation, where it facilitates the retro-translocation process of misfolded proteins
physiological function
-
overexpressing splicing variant RHX6 in breast cancer cells leads to retarded proliferation, migration, and decreased production of epithelial-mesenchymal transition-related adhesion molecules. Mechanically, RHX6 is able to inhibit the maturation of tumor necrosis factor alpha-converting enzyme, a protease that processes pro-transforming growth factor alpha, a pro-ligand of epidermal growth factor receptor, and to prevent intracellular transportation of pro-transforming growth factor alpha to the cell surface
physiological function
-
the levels of isoform RHBDL4 modulate the shape and distribution of the endoplasmic reticulum (ER), especially during conditions that require rapid changes in the ER sheet distribution, such as ER stress
physiological function
-
enzyme overexpression has a negative impact on growth under static conditions, suggesting an effect on denitrification enzymes and/or high oxygen affinity cytochrome c oxidase required for growth in low oxygen tension conditions
physiological function
-
cold-induced degradation of fatty acid export protein 1 by the enzyme is critical for Arabidopsis to survive cold and freezing periods
physiological function
the enzyme is involved in the retrotranslocation of ubiquitinated endoplasmic reticulum-associated degradation membrane substrates. The enzyme interacts specifically with endoplasmic reticulum membrane substrates, but not luminal substrates
physiological function
-
the enzyme is involved in the retrotranslocation of ubiquitinated endoplasmic reticulum-associated degradation membrane substrates. The enzyme interacts specifically with endoplasmic reticulum membrane substrates, but not luminal substrates
physiological function
-
enzyme forms GlpG and Rhom7 are involved in membrane protein quality control by specifically targeting components of respiratory complexes. The enzymes prevent aggregation of orphan substrates in the inner membrane. Isoform GlpG specifically targets orphan HybA and does not influence hydrogenase-2 activity
physiological function
-
enzyme overexpression has a negative impact on growth under static conditions, suggesting an effect on denitrification enzymes and/or high oxygen affinity cytochrome c oxidase required for growth in low oxygen tension conditions
-
physiological function
-
a gene deletion mutant shows reduced motility and increased sensitivity to novobiocin. Mutant membrane preparations are enriched in glycoproteins S-layer glycoprotein and an ABC transporter component. The mutant S-layer glycoprotein contains the oligosaccharide GlcNAc2(Hex)2-6-deoxy-6-sulfoglucose-Hex-6-deoxy-6-sulfoglucose bound to residue N732, while the wild type glycoprotein releases the oligosaccharide species GlcNAc-GlcNAc(Hex)2-(6-deoxy-6-sulfoglucose)-Hex6
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
A253I
the mutant exhibits 16% of wild type activity towards the wild type TatA protein but shows 87% of wild type activity on TatA mutant A8G
A253L
the mutant exhibits no activity of wild type activity towards the wild type TatA protein but shows 23% of wild type activity on TatA mutant A8G
A253T
the mutant exhibits 37% of wild type activity towards the wild type TatA protein but shows 63% of wild type activity on TatA mutant A8G
A253V
the mutant exhibits 63% of wild type activity towards the wild type TatA protein but shows 144% of wild type activity on TatA mutant
D18A
mutation in residue conserved among 32 sequenced prokaryotic rhomboids. No significant change in activity is observed
D243A
site-directed mutagenesis, the mutant shows similar activity as the wild-type enzyme
E42A
mutation in residue conserved among 32 sequenced prokaryotic rhomboids. No significant change in activity is observed
F133Y/F135Y
site-directed mutagenesis, almost inactive mutant
F139S
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
F153A
-
the mutant shows approximately a 2.5times activity enhancement compared to the wild type enzyme
F153C/W236C
-
the mutations increase the activity 3fold compared to the wild type enzyme
F245A
site-directed mutagenesis, the enzyme shows increased activity compared to the wild-type enzyme
G199A
site-directed mutagenesis, inactive mutant
G257A
site-directed mutagenesis, inactive mutant
H141F
decrease in transition temperature by 6 degrees. Mutant retains almost no activity
H141T
decrease in transition temperature by 11-12 degrees. Mutant retains some activity
H141V
decrease in transition temperature by 11-12 degrees. Mutant retains some activity
H145A
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
H150A
the mutation leads to a complete loss of activity
H2541X
using mutagenesis it is shown that His254 is catalytically essential
L143S
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
L244A
site-directed mutagenesis, the mutant shows similar activity as the wild-type enzyme
M247A
site-directed mutagenesis, the mutant shows similar activity as the wild-type enzyme
M249A
site-directed mutagenesis, the enzyme shows increased activity compared to the wild-type enzyme
M3A
mutation in residue conserved among 32 sequenced prokaryotic rhomboids. No significant change in activity is observed
N154A/H254A
mutation induces larger destabilization
N154A/S201A
mutation induces larger destabilization
N251A
site-directed mutagenesis, inactive mutant
N33P
mutation promotes domain-swapped dimer formation, due to probably a lower entropic barrier of proteinprotein association
Q14A
mutation in residue conserved among 32 sequenced prokaryotic rhomboids. No significant change in activity is observed
Q189A
no catalytic activity, thermostability of mutant is indistinguishable from wild-type
Q189T
no catalytic activity, thermostability of mutant is indistinguishable from wild-type
Q30A
mutation in residue conserved among 32 sequenced prokaryotic rhomboids. No significant change in activity is observed
R11A
mutation in residue conserved among 32 sequenced prokaryotic rhomboids. No significant change in activity is observed
R137A
site-directed mutagenesis, inactive mutant
R49A
mutation in residue conserved among 32 sequenced prokaryotic rhomboids. No significant change in activity is observed
S185T
mutant retains proteolyitc activity
S185V
transition temperature similar to wild-type, no catalytic activity
S201A/H254A
double mutation on the catalytic dyad, yields a smaller decrease in the stability than individual single mutations
S201X
using mutagenesis it is shown that Ser201 is catalytically essential
S68A
mutation in residue conserved among 32 sequenced prokaryotic rhomboids. No significant change in activity is observed
T22A
mutation in residue conserved among 32 sequenced prokaryotic rhomboids. No significant change in activity is observed
W136A
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
W157A/F232A
site-directed mutagenesis, the enzyme shows 6fold increased activity compared to the wild-type enzyme
W236A
-
the mutant shows approximately a 2.5times activity enhancement compared to the wild type enzyme
W38A
mutation in residue conserved among 32 sequenced prokaryotic rhomboids. No significant change in activity is observed
Y138D
site-directed mutagenesis, inactive mutant
Y138F
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
Y138S
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
Y138S/F139S
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
Y138Y
site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
Y205A
site-directed mutagenesis, inactive mutant
F137A
the mutant shows 14% of the wild type activity
F144A
the mutation results in a 42% decrease in activity compared with the wild type enzyme
F160A
the mutant decreases peptidase activity by 54% compared to wild type enzyme
F68A
the substitution has no effect on activity (98% activity compared to the wild type enzyme)
F76A
the mutation results in a 95% decrease in activity compared with the wild type enzyme
F84A
the mutant shows 5% of the wild type activity
L136A
the mutant shows 22% of the wild type activity
M164A
the mutant decreases peptidase activity by 40% compared to wild type enzyme
W72A
the mutant is not expressed and activity cannot be assessed
W72A/F76A/F144A
the three alanine substitutions result in a 2.5fold increase in activity compared to wild type enzyme
W72V/F76V/F144V
the three valine substitutions result in a 2fold increase in activity compared to wild type enzyme
G121F/C122F/G125F/S126F
-
the mutations completely abolish cleavage of MHC202
G125F/S126F
-
the mutations partially reduced cleavage of MHC202
R111A
-
processing of RHBDL2 is totally abolished
W110A
-
when cells are transfected with W110A, RHBDL2 is processed
A78E
-
mutant shows rhomboid activity but does not undergo proteolytic modification (beta-cleavage)
DELTA75-79
-
mutant Parl, where beta-cleavage is abolished by removing (DELTA75KRSAL79) or mutating the beta-cleavage site (L79E) do not induce fragmentation, indicating that the processing is a gain of function
L79E
-
mutant shows rhomboid activity but does not undergo proteolytic modification (beta-cleavage)
R76E
-
mutant shows rhomboid activity but does not undergo proteolytic modification (beta-cleavage)
S144A
-
active site mutant
S65D
-
proteolytic modification (beta-cleavage) is blocked by phosphorylation of residues located in close proximity to the cleavage site. Phosphomimetic substitutions of these amino acids impair the processing without affecting Parl rhomboid activity
S70D
-
proteolytic modification (beta-cleavage) is blocked by phosphorylation of residues located in close proximity to the cleavage site. Phosphomimetic substitutions of these amino acids impair the processing without affecting Parl rhomboid activity
S77E
-
mutant shows rhomboid activity but does not undergo proteolytic modification (beta-cleavage)
T69D
-
proteolytic modification (beta-cleavage) is blocked by phosphorylation of residues located in close proximity to the cleavage site. Phosphomimetic substitutions of these amino acids impair the processing without affecting Parl rhomboid activity
H2541X
-
using mutagenesis it is shown that His254 is catalytically essential
S201X
-
using mutagenesis it is shown that Ser201 is catalytically essential
F58A
the mutation results in high steady-state levels of SUS and a strong block in Hmg2 degradation as well as the inability to bind Hmg2
F66A
the mutant does not disrupt enzyme-mediated degradation of SUS and Hmg2 and is able to support substrate binding
G120D
-
the mutant is defective in substrate processing and exhibits respiratory growth defects that correlate with loss of mitochondrial genome stability
G233D
-
the mutant is defective in substrate processing and exhibits respiratory growth defects that correlate with loss of mitochondrial genome stability
G233S/V321A
-
the mutant is defective in substrate processing and exhibits respiratory growth defects that correlate with loss of mitochondrial genome stability
G315D
-
the mutant is defective in substrate processing and exhibits respiratory growth defects that correlate with loss of mitochondrial genome stability
H313A
-
mutation of the catalytic residue leads to a complete loss activity
I71A
the mutation results in high steady-state levels of SUS and a strong block in Hmg2 degradation as well as the inability to bind Hmg2
K67A
the mutation results in high steady-state levels of SUS and a strong block in Hmg2 degradation as well as the inability to bind Hmg2
K68A
the mutation results in high steady-state levels of SUS and a strong block in Hmg2 degradation as well as the inability to bind Hmg2
L64A
the mutation results in high steady-state levels of SUS and a strong block in Hmg2 degradation as well as the inability to bind Hmg2
L75A
the mutation results in high steady-state levels of SUS and a strong block in Hmg2 degradation as well as the inability to bind Hmg2
Q70A
the mutation results in high steady-state levels of SUS and a strong block in Hmg2 degradation as well as the inability to bind Hmg2
R73A
the mutation results in high steady-state levels of SUS and a strong block in Hmg2 degradation as well as the inability to bind Hmg2
S252N
-
the mutant is defective in substrate processing and exhibits respiratory growth defects that correlate with loss of mitochondrial genome stability
S256A
-
mutation of the catalytic residue leads to a complete loss activity
V69A
the mutant does not disrupt enzyme-mediated degradation of SUS and Hmg2 and is able to support substrate binding
W62A
the mutant does not disrupt enzyme-mediated degradation of SUS and Hmg2 and is able to support substrate binding
W72A
the mutation results in high steady-state levels of SUS and a strong block in Hmg2 degradation as well as the inability to bind Hmg2
G120D
-
the mutant is defective in substrate processing and exhibits respiratory growth defects that correlate with loss of mitochondrial genome stability
-
G233D
-
the mutant is defective in substrate processing and exhibits respiratory growth defects that correlate with loss of mitochondrial genome stability
-
G233S/V321A
-
the mutant is defective in substrate processing and exhibits respiratory growth defects that correlate with loss of mitochondrial genome stability
-
G315D
-
the mutant is defective in substrate processing and exhibits respiratory growth defects that correlate with loss of mitochondrial genome stability
-
S252N
-
the mutant is defective in substrate processing and exhibits respiratory growth defects that correlate with loss of mitochondrial genome stability
-
D256A/R257A
-
Golgi localisation is not affected in the mutant protein
F36A/F37A
-
mutant is still targeted efficiently to the Golgi compartment, indicating that in TgROM2 there are two crucial signal elements responsible for Golgi targeting
F36A/F37A/D256A/R257A
-
Golgi localisation is not affected in the mutant protein
F54A/P55S/H56A/F57A
-
micronemes localisation is abolished
H2541X
-
using mutagenesis it is shown that His254 is catalytically essential
S201X
-
using mutagenesis it is shown that Ser201 is catalytically essential
S150A
-
active site mutant. In contrast to the wild-type, only a band of 33000 Da is seen on SDS-PAGE
F153A/W236A

site-directed mutagenesis, the enzyme shows 10fold increased activity compared to the wild-type enzyme
F153A/W236A
-
the mutant shows approximately a 5times activity enhancement compared to the wild type enzyme
H254A

site-directed mutagenesis, inactive mutant
H254A
complete loss of activity
L229V/F232V/W236V

site-directed mutagenesis, the enzyme shows 4fold increased activity compared to the wild-type enzyme
L229V/F232V/W236V
mutation of the TM5 helix leads to a significant enhanced activity. The structures of the TM segments does not change significantly in the triple-Val mutant, but, due to the smaller size of the Val relative to the wild-type residues (Trp, Phe, and Leu), the accessibility of the catalytic Ser from the lateral side increased. This change alone helps explain the enhanced activity of the triple-Val mutant
N154A

site-directed mutagenesis, almost inactive mutant
N154A
complete loss of activity
S201A

site-directed mutagenesis, inactive mutant
S201A
complete loss of activity
S201A
-
active site mutant
W157C/F232C

site-directed mutagenesis, the enzyme shows reduced activity compared to the wild-type enzyme
W157C/F232C
-
the mutations increase the activity 2fold compared to the wild type enzyme
Y138S/F139S/L143S

site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme
Y138S/F139S/L143S
mutation of the L1 loop leads to a significant reduced activity. The triple-Ser mutation in the L1 loop affects the orientation of the protein within the lipid bilayer and the location of the catalytic Ser
Y160C/L229C

site-directed mutagenesis, the enzyme shows highly reduced activity compared to the wild-type enzyme
Y160C/L229C
-
the mutant remains similar activity compared to the wild type enzyme
L262V

-
genetic variation is associated with insulin-resistance in an age-dependent manner
L262V
-
in an Irish case-control population it is shown that the Leu262Val polymorphism of presenilin associated rhomboid like protein (PARL) is associated with earlier onset of type 2 diabetes and increased urinary microalbumin creatinine ratio
L262V
-
in 1031 human subjects a conserved amino acid substitution (L262V) in Parl is associated with increased plasma insulin concentration, a key risk factor for diabetes
S150A

-
site-directed mutagenesis, catalytic residue mutation, inactive mutant
S150A
active site mutant. In contrast to the wild-type, only a band of 33000 Da is seen on SDS-PAGE
S150A
-
site-directed mutagenesis, catalytic residue mutation, inactive mutant
-
additional information

-
expression of Tic40 in enzyme-deficient yeast cells using the Escherichia coli shuttle vector YEplac195, comparison with the two yeast mitochondrial rhomboid protease substrates, Ccp1 and Mgm1, analysis of effects on the enzyme activity, overview
additional information
-
enzyme knockout strains show no phenotype
additional information
-
activity is abolished with a catalytic serine to alanine mutant
additional information
engineered mutants in the L1 loop and active-site region of the GlpG rhomboid protease suggest an important structural, rather than dynamic, gating function for the L1 loop, conversely, three classes of mutations that promote transmembrane helix 5 displacement away from the protease core dramatically enhance enzyme activity 4 to 10fold
additional information
-
enzyme knockout strains show no phenotype
additional information
expression of the isolated membrane domain. Catalytic parameters for the domain are not significantly different in comparison to the full-length protein. Similar to wild-type, membrane domain formsdimers
additional information
-
expression of the isolated membrane domain. Catalytic parameters for the domain are not significantly different in comparison to the full-length protein. Similar to wild-type, membrane domain formsdimers
additional information
-
expression of Tic40 in enzyme-deficient yeast cells using the Escherichia coli shuttle vector YEplac195, comparison with the two yeast mitochondrial rhomboid protease substrates, Ccp1 and Mgm1, analysis of effects on the enzyme activity, overview
additional information
-
construction of aarA knockout mutants, AarA mutants are defective in Tat function and rescued by tatA in multicopy, TatA protein missing the first 7 amino acids restores the aarA-dependent phenotypes, the Tat system is responsible for the various phenotypes exhibited by an aarA mutant, e.g. in extracellular signal production, overview
additional information
-
construction of aarA knockout mutants, AarA mutants are defective in Tat function and rescued by tatA in multicopy, TatA protein missing the first 7 amino acids restores the aarA-dependent phenotypes, the Tat system is responsible for the various phenotypes exhibited by an aarA mutant, e.g. in extracellular signal production, overview
-
additional information
-
expression of Tic40 in enzyme-deficient yeast cells using the Escherichia coli shuttle vector YEplac195, comparison with the two yeast mitochondrial rhomboid protease substrates, Ccp1 and Mgm1, analysis of effects on the enzyme activity, overview
additional information
-
pcp1-deleted cells has a slow growth phenotype and contain unprocessed Mgm1
additional information
construction of ROM1-knockout mutant, ROM1-deficient parasites are outcompeted by wild-type Toxoplasma gondii, the ROM1-deficient parasites show only modest decrease in invasion but replicate more slowly than wild-type cells, overview
additional information
-
construction of ROM1-knockout mutant, ROM1-deficient parasites are outcompeted by wild-type Toxoplasma gondii, the ROM1-deficient parasites show only modest decrease in invasion but replicate more slowly than wild-type cells, overview
additional information
-
by analyzing chimeric proteins it is shown that the N-terminal domain of TgROM2 is sufficient to confer Golgi localisation to related ROM proteins that are normally localised to the plasma membrane or to micronemes. F36 and F37 are crucial in this targeting process
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.